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 The data presented in Chapter II was fundamental towards  reaching goal 3, discovering a 
mechanism of Golgi stress.  
For this project, some of the Golgi stresses discovered and our criterion for measuring 
them, were deeply explored to find the mechanism. An initial observation, that thapsigargin 
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 In mammals, the Golgi apparatus has a unique stacked structure that is important for its 
function; yet, the Golgi structure is dynamic and its structure and function changes in response to 
different stress conditions applied to the cell. Since Golgi functions are abnormal in stress, it 
implies that Golgi structure may play a critical role in human diseases.  
 This research project studied how the Golgi apparatus responds to stress. The study 
process followed in a stepwise progression:  First, it was necessary to determine how the Golgi 
responded to endoplasmic reticulum (ER) stress; findings indicated that the Golgi is fragmented 
in response to thapsigargin (TG) but not to other ER stress inducers such as tunicamycin (Tm) 
and dithiothreitol (DTT).  Since TG treatment is known to cause an increase in cytosolic 
calcium, it was useful to determine whether a calcium-sensitive kinase could act as the trigger of 
Golgi morphological change. This led to identification of protein kinase C-α (PKCα) and its 
substrate GRASP55 in calcium stress-induced Golgi fragmentation, and abnormal Golgi 
functions. More generally, cytosolic calcium is a logical trigger in the Golgi structure alteration 
process during stress, as it has been shown to be regulated during several cellular processes. 
Subsequently, this study confirmed that activating or inflammatory agents induce Golgi 
fragmentation and cytosolic calcium increase via a similar mechanism.  
 These findings are of great interest to cell biologists who are working on Golgi dynamics, 
membrane trafficking, cellular responses to stresses, and histamine biology. 
 Next, several novel findings are described where, reactive oxidative species (ROS) 
induce the degradation of Golgi structural proteins in the trans-Golgi, including Arl1, Golgin-97, 
and Golgin-245, and thereby impair membrane trafficking. 
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This work is believed to be the first systematic study of how ROS affects Golgi structure 
and function. It revealed the trans-Golgi and trafficking at the trans-Golgi as novel targets of 
ROS in cells, which may help understand the toxicity of ROS in human diseases.  It also found 
that the degradation of Arl1, Golgin-97 and Golgin-245 is not mediated by proteasomes nor 
lysosomes, but rather by cytosolic proteases. This finding underscores the importance of 
cytosolic proteases whose importance has been often underestimated in recent studies. 
 During this study, some molecular tools were designed and constructed to detect Golgi 
calcium signals in cells using GCaMP-based sensors. The main advantage of this sensor is that 
the GCaMP calcium probe is covalently linked to GRASP55 on the Golgi and can directly sense 
and detect fluctuations of local cytoplasmic calcium in the vicinity of the Golgi. This tool is 
essentially a de facto Golgi stress sensor, which can be used by others who wish to quickly 
screen for compounds that reduce calcium-related Golgi fragmentation during stress. 
 Besides calcium imaging was an opportunity to develop another set of tools for imaging 
specific proteins of interest at the ultrastructural level. These sensors utilize a recombinant 
ascorbate peroxidase (apex) enzyme to catalytically precipitate an electron dense product in the 
vicinity of a cellular protein of interest. In the lab the apex gene was linked to each GRASP55 
and GRASP65 with the hopes that future researchers will utilize this fusion protein to identify 
















1.1 Overview of the exocytic and endocytic trafficking system  
The cell is a highly ordered machine in large part due to a correctly functioning endocytic 
trafficking system (Fig. 1.1) (Glick and Nakano, 2009). For conventionally secreted proteins, 
newly synthesized polypeptides in the endoplasmic reticulum (ER) are folded and packaged into 
transport carriers. The nascent polypeptides and lipids then progress through the intermediate 
compartments and make their way to the Golgi apparatus (Saraste and Marie, 2018). Transport 
vesicles fuse and their contents begin a modification process with numerous essential surface 
features, including sugar and phosphate groups, as they make their way through the Golgi. 
Trafficking between Golgi compartments relies on a group of long coiled-coil proteins called 
golgins, which act as membrane tethers to capture vesicles and facilitate their fusion with the 
Golgi membranes (Lupashin and Sztul, 2005; Muschalik and Munro, 2018; Witkos and Lowe, 




1 The data from Figure 1.4 was revised from works referenced in the corresponding figure legend 
and in the text related to the figure. Figure 1.6 from this chapter was modified from data 
originally published in Golgi biogenesis. Cold Spring Harb Perspect Biol, 2011. 3(10): p. 




Maturation of biosynthetic products often must be a sequential process, and there are two 
competing models of how this occurs; in one model enzymes are located in a systematic way 
within an assembly line composed of maturing cisternae, this is also mediated by membrane 
tethers (Munro, 2011). Anterograde movement through the Golgi is mediated by packaging into 
discrete units called COPII vesicles that coalesce to form new Golgi cisternae (McCaughey and 
Stephens, 2018). Retrograde travel to return cargo, Golgi enzymes, or endocytosed materials to 
an earlier stage of the endocytic trafficking system including the Golgi happens via COPI 
vesicles (Ishii et al., 2016).  A third type of vesicle, clathrin-coated vesicles are destined for 
endosome/autophagosome via multivesicular bodies. Clathrin-coated vesicles originate from an 
area of the Golgi called the trans-Golgi network (TGN) and were discovered to also emerge from 
the plasma membrane (Mettlen et al., 2018). The Golgi cisternae, however,  seem to be stable 
compartments that accept cargo via incoming COPII vesicles from the ER.  
 
Whatever model of Golgi transport one embraces, protein products are packaged and leave the 
Golgi toward destinations within and outside the cell (Pantazopoulou and Glick, 2019). The 
Golgi processes many important proteins, but there are examples of secreted proteins that bypass 
the Golgi apparatus, which are altogether called unconventionally secreted proteins; but these 
will not be discussed in detail here. In general, the Golgi apparatus must balance biosynthetic 
and degradative pathways and can be characterized as a factory in the cell. The Golgi therefore 





1.1.1 Introduction to the Golgi apparatus 
The Golgi apparatus is a membrane organelle in the center of the endomembrane system. It is 
responsible for protein and lipid trafficking, processing, and secretion. As many as 30% of all 
proteins encoded by the human genome, including hormones, enzymes, and immunoglobulins, 
are processed by the Golgi with speed and fidelity (Pfeffer, 2010).  The Golgi has a unique and 
recognizable shape as a stacked structure of parallel flattened cisternae (Fig. 1.1). It is located 
adjacent to the centrosome, near the center of most cell types along with the nucleus (Fig. 1.2). 
There are on average a few dozen Golgi stacks per cell which are connected laterally to form the 
so-called "Golgi ribbon."  
 
The structure of the Golgi is physically dynamic.  During cell cycle progression, it is reversibly 
disassembled  (Barr et al., 1997).  During programmed cell death it is irreversibly disassembled 
(Mancini et al., 2000). An important aspect of Golgi biology is that its structure determines its 
functions (Fig. 1.3). 
 
1.1.2 Golgi structure and position 
The Golgi stack has essential structural features.  It is polarized and it contains distinct cis-/trans-
compartments. In general, incoming cargo, received from the ER, is progressively modified until 
the product is sorted and sent to its required destination.  
 
In the evolutionary past, the Golgi’s polarity presented cells with a problem during mitosis, a 
process in which the cell and each organelle must divide in half.  The problem was, how to 
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ensure the next generation of cells would have equal proportions of the Golgi arranged in the 
proper way.  
 
The cell’s solution for equal proportioning of the Golgi apparatus during cell division is an 
elegant disassembly and reassembly process with well-defined phases. During mitosis, the Golgi 
ribbon becomes untethered, the stacks become unstacked, and the cisternae are shortened and 
become vesiculated (Tang et al., 2012). Vesiculation permits vesicles to spread evenly 
throughout the cytoplasm. At the end of mitosis in telophase, the entire process runs in reverse. 
Vesicles fuse depending on their constituent parts and membranes restack to form the Golgi 
ribbons again. This well-choreographed process depends on the careful coordination of many 
molecular machineries in the cell including kinases and phosphatases, ubiquitin ligases and 
deubiquitinases, vesicle fission and fusion machineries as well as many others. 
 
In interphase, the Golgi ribbon in mammalian cells forms near the microtubule organizing center 
(MTOC) of the cell near the centrosome (Yadav and Linstedt, 2011). There are some exceptions, 
but this study observed the normal Golgi shape at the ultrastructural level is an elaborate 
complex of four-to-eight long membranous, stacked cisternae that connect laterally to form an 
articulated ribbon (Fig. 1.3B). This ribbon is held in place due to the persistent actions of the 
microtubule minus-end directed motor protein Dynein that carries Golgi membranes to a 
pericentriolar region along microtubule network. Microtubules are required for lateral linking of 
the Golgi ribbon. It was found that treatment of cells with the microtubule depolymerizing drug 




1.1.3 Golgi function and significance 
While the Golgi has a recognizable structure, it is not always clearly understood what it does. 
However, viewing the Golgi as a factory in the cell is a useful analogy.  A factory receives inputs 
from outside sources and assembles larger, more complex, items from the basic building block 
components. Once the product is boxed and labeled, the item is loaded on a vehicle for delivery.  
 
In the Golgi/factory analogy, the primary function of the Golgi involves the processes of material 
handling, modifications, and sorting, to produce secretory proteins and lipids. During processing 
there is a step-wise exposure of secretory traffic to the unique enzyme and sorting machinery 
containing compartments of the Golgi apparatus. As these cargos are exposed to enzymes in each 
Golgi cisternae, they are processed with modifications such as glycosylation and phosphorylation 
and grow in complexity (Capasso et al., 1989; Fleischer, 1983).  
 
Many protein products encoded by the human genome would have no function if not for further 
processing by the Golgi apparatus (Miyoshi et al., 2020).  A particular example takes place in 
professional secretory cells called goblet cells lining mucous membranes (Araujo et al., 2019). 
These cells produce abundant amounts of pre-glycoproteins called mucins that are received by 
the Golgi.  There, they are modified with carbohydrate additions called O-GalNAc glycans by 
the activity of polypeptide O-GalNAc-transferases (GALNTs) (Brockhausen and Stanley, 2015). 
When ready, mature mucus molecules are secreted via secretory granules.  This is the highly 
"sticky" substance that traps invaders in the respiratory system before they can do much harm. In 
this sense, the Golgi adds and refines the biological materials with more information and 




Proteins can be modified with numerous modifications in the Golgi and would not function 
properly otherwise; these proteins include immunoglobulins, neurotransmitters, growth factors, 
cell surface receptors, cell adhesion molecules, and many others needed for organism health and 
survival. 
 
1.2 Golgi stress definition, types, and regulators 
Golgi stress can be defined as perturbations of Golgi functions of sorting, trafficking and 
modifications. Because the Golgi lies in the middle of the membrane trafficking pathway and 
may house the majority of enzymes in the cell (Colley, 1997), disorganization of Golgi 
membranes often causes abrupt biological and morphological changes within the cell necessary 
to maintain homeostasis. 
 
Researchers have developed numerous ways to observe Golgi structural disorganization in the 
cell including by using various modalities of microscopy including immunofluorescence (Thayer 
et al., 2013), and electron microscopy (EM) (Bekier et al., 2017). These researchers have broken 
down structural change into several metrics which include swelling, enlargement, compaction, 
disorganization, fragmentation, and so on. However, we will define Golgi structural 
disorganization during stress as "fragmentation" to contrast it with the "disassembly" that occurs 
during the cell cycle. 
 
The Golgi is fragmented and exhibits signs of morphological and functional changes in several 
major human diseases including Alzheimer’s, cancer, and amyotrophic lateral sclerosis (ALS) 
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(Fig. 1.4A-B) (Mourelatos et al., 1996; Petrosyan, 2015; Sundaramoorthy et al., 2015). Some 
stresses including overactivation of neurons also induce a clear Golgi fragmentation phenotype 
(Fig. 1.4C-F) (Thayer et al., 2013).  
 
Although the Golgi is directly responsible for the proper functioning of proteins essential for 
human health and survival, little is known about the biological processes that lead to Golgi 
fragmentation and Golgi functions during stress and disease. Intermediate steps could be 
required to transduce a change of the Golgi, such as secondary messengers like calcium or 
reactive oxygen species (ROS). It is also not known to what extent exogenous or endogenous 
stresses play in Golgi functions. How the Golgi looks during dynamic regulation to respond to 
multiple types of cellular stress, or damage by stress leading to functional consequences for the 
cell, is the topic of this research investigation. 
 
Cellular stress is not a new field of study. Some things are known about the Golgi with respect to 
known stress pathways. One example of the tight coupling of secretory pathway stress responses, 
is the relationship between the endoplasmic reticulum unfolded protein response (UPR) and 
Golgi stress. This connection has been hypothesized by Oku et al. to be due to a rapid increase of 
substrates in the Golgi as the ER rapidly produces secretory and membrane proteins during UPR, 
placing increasing demands on the Golgi by cargo crowding (Oku et al., 2011). The Golgi’s 
unique stacked structure could provide a mechanism to balance the speed by which biochemical 
modifications can be made, with the fidelity. For example, if there is a robust increase in demand 
on glycolytic processing, then it might benefit the cell to decrease Golgi stacking and increase 
membrane surface area. Experimental data covered in Chapter II showed this was the case. In 
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Chapter II, questions are raised concerning whether the Golgi morphological changes, that 
occur as a consequence to ER stress inducing drugs, actually precede the well characterized 
UPR.  Since, the Golgi structure becomes smaller and more compact upon starvation, and 
fragments during apoptosis,  any explanation of Golgi fragmentation must account for the 
occurrence during normal conditions including cell division and apoptosis. 
 
If the Golgi is indeed not responding to ER stress but actually has the ability to enact its own 
changes in the cell in response to external triggers this brings up an intriguing possibility. A 
growing body of work, including this study, shows that there are Golgi-specific stress pathways 
in the cell. Many groups have reported that Golgi-associated genes, including glycosylation 
enzymes and vesicular trafficking components are upregulated during Golgi stress, along with 
Golgi fragmentation. For example, mutations that disrupt Golgi structural organization, such as 
those genes encoding seven of the eight conserved oligomeric Golgi complex (COG) subunits, 
result in malfunctions in protein processing and congenital defects of glycosylation (Smith and 
Lupashin, 2008). There is/are likely also one or more sensors in the Golgi that are able to 
recognize a need for up-regulation of Golgi genes. An example is when the function of the Golgi 
was disturbed in Oku et al., transcription from the cis-activating Golgi stress response element 
(GASE) was induced, which in turn upregulated glycosylation enzymes and post-Golgi vesicular 
trafficking factors (Oku et al., 2011). It will be shown, too, that other Golgi morphological 
changes likely take place in response to phosphorylation of Golgi matrix components such as the 





A potentially significant consequence of the Golgi-specific stress hypothesis is that perhaps 
imbalanced pathways can be returned to a normal, non-diseased state by utilizing a pre-existing 
mechanism within the cell. A basic problem arising when considering the question of Golgi 
stress carefully is whether it is the Golgi detecting cellular stress and influencing other pathways, 
or is it reacting to existing problems within the cell producing stress responses as the influence of 
these problems reach some triggering level. My current understanding is that the truth lies 
somewhere in the middle; that the Golgi has the ability to both detect and respond to cellular 
stress, but this is largely based on both the type and duration of the specific insult.  
 
Some examples of Golgi fragmentation exist during normal cellular development, such as during 
mitosis and apoptosis.  Since these normal functions could potentially obfuscate an analysis of a 
Golgi-specific stress response using only fragmentation, other types of measurement and many 
controls are required.  
 
1.2.1 Golgi stress in the context of the cell 
There are many examples of cellular stress conditions in the literature. A list of proteins that 
have increased protein expression as a result of stressful stimuli was made from three published 
general cellular stress response screens (Alvarez-Miranda et al., 2015; Chia et al., 2012; Millarte 
et al., 2015). All the proteins published in these screens were upregulated by the induction of at 
least one of seven cellular damage response categories, i.e.,  DNA damage, ER stress, 
inflammation, osmotic pressure, oxidation, pH imbalance, and starvation (Fig. 1.5A). Of these 
stress categories, several are known to produce Golgi fragmentation in various cell types and 
tissues. Preliminary work for this study verified whether these stress categories caused Golgi 
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fragmentation in HeLa cells in cell culture. Preliminary experiments indicated many stress 
categories were indeed able to cause Golgi fragmentation phenotypes in HeLa cells. 
 
1.2.2 Golgi plasticity in response to stress conditions  
Golgi structure altering stresses include ER stress, inflammation, pH imbalance, and others (Fig. 
1.5A). There are a wide array of stress-induced Golgi structural phenotypes, including 
compacted and diffused, but one of the most common is fragmentation (Fig. 1.5D-E).  An 
exhaustive review of each stressful condition was beyond the scope of this study. 
 
The most critical stresses that affect Golgi structure, in particular those that produce 
fragmentation and changes in Golgi biology, will be briefly discussed. For background, the 
following are short summaries of stresses recounted in literature that cause Golgi responses. 
 
pH 
The concentration of H+ ions is believed a major factor in contributing to the organization of the 
Golgi (Kellokumpu, 2019). The interplay between cytosol pH and Golgi lumen pH is thought to 
be an important regulatory mechanism that influences trafficking. Cytosolic pH in most cells is 
approximately 7.2 and the Golgi pH has been reported from 6.25 – 6.58 (Schapiro and Grinstein, 
2000).  
 
The pH of the Golgi luminal compartment decreases in the direction of the plasma membrane. 
The pH gradient across the Golgi membrane is maintained by V-ATPases that undergo active ion 
transport. Many enzymes have an acidic pH requirement. For example, mannose-6-phosphate 
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receptors (M6PR) are transmembrane glycoproteins that undergo pH-dependent targeting of 
lysosomal enzymes to acidic organelles where they can carry out their function. Recycling of 
M6PR is important for cellular homeostasis and depends on Golgi pH (Lin et al., 2004). 
Treatment of cells with monensin, a drug that increases pH of the Golgi lumen to neutral levels, 
also prevents recycling of sorting receptors (Basu et al., 1981). Mutations of critical enzymes in 
the Golgi, which lead to dysregulation of pH, can also lead to protein trafficking defects and 
accumulation of byproducts in the lysosome or extracellular space. Therefore, the Golgi pH is 
important to maintain cellular homeostasis and health. 
 
Calcium 
Under stress conditions, free calcium and calcium sensitive enzymes have been shown to 
increase in the cytoplasm. The cytosolic Ca2+ level at rest is ~100 nM (Garrity et al., 2016; 
Zampese and Pizzo, 2012). During physiological stimulation, cytosolic free calcium can climb to 
3 μM (Celsi et al., 2009). Cytosolic calcium is suppressed during mitosis (Kiehart, 1981). 
Dysregulation of calcium is known to accompany Golgi fragmentation (Nakagomi et al., 2008). 
Cytosolic calcium dysregulation appears in Alzheimer's disease. In the presence of amyloid 
precursor protein (APP), calpain, a calcium sensitive furin-like protease, catalyzes the conversion 
of p35 to p25.  Then, p25 activates Cdk5, which phosphorylates GRASP65 in response to 
amyloid-β (Aβ) accumulation. Fragmentation of Golgi enhances trafficking of APP (Joshi et al., 
2014). Therefore, it appears that changes in cytosolic or Golgi calcium during stress could cause 




The Golgi can handle cellular calcium and is important for calcium homeostasis (Dolman and 
Tepikin, 2006). Calcium handling depends on Golgi calcium channels and transporters to reduce 
cytosolic ion concentration. The Golgi has Ca2+ channels in common with the ER: inositol 
triphosphate receptors (IP3Rs) and sarco/endoplasmic reticulum ATPase isoform 2b (SERCA2b) 
on its cis-face, and ryanodine receptors (RyRs) and secretory pathway ATPases (SPCA1) mostly 
on its trans-face. IP3Rs are calcium efflux channels that respond to inositol triphosphatase (IP3) 
and regulate the release of calcium from the ER or Golgi lumen. SERCA2b is a ubiquitously 
expressed ATPase that can bind two cytosolic calcium ions at once, burning ATP to move them 
into the Golgi lumen. SPCA1 also burns ATP to move divalent cations (Ca2+ and Mg2+ ) from 
the cytosol into the luminal space. These pumps and transporters may be significant to cytosolic 
processes that are dependent on these ions. Damage to these components could occur during 
stress due to oxidative damage, lipid peroxidation and membrane deposition of aggregated 
proteins (Nakagomi et al., 2008). It may be possible that cytosolic calcium homeostasis is 
disrupted at critical times, like after damage to these proteins.  
 
The Golgi is also known to store, and itself use, cellular calcium (Dolman and Tepikin, 2006). 
Calcium is tightly regulated within the Golgi apparatus by binding proteins. The Golgi apparatus 
has 4 known calcium binding proteins, Cab45, CALNUC, p54/NEFA and calumenin (Dolman 
and Tepikin, 2006). In addition, both Ca2+ and Mg2+ act as required biosynthetic co-factors 
within the Golgi lumen. The Golgi is somewhat resistant to calcium fluctuations, suggesting that 
changes in Golgi calcium concentration may result in disruption of Golgi processes, such as 
membrane trafficking, signal transduction, organelle homeostasis, and organelle acidification 




There is a novel mechanism, discussed in Chapter II, that coordinates Golgi structure and 
perhaps function: Increased cytoplasmic Ca2+, which activates PKCα, and subsequently 
phosphorylates GRASP55, impairs its function in Golgi structure organization. 
 
Osmotic Pressure 
Cellular responses to osmotic stress share much overlap with calcium handling, because 
excretion of solutes is not only the mechanism of reducing calcium concentration in the cell but 
also water movement out of the cell in a hypotonic environment. Similarly, absorption of solutes 
is the cellular response to hypertonic environments and allows cells to cope with stress, making 
the most energetically efficient means of coping with these stress pathways to overlap regulatory 
pathways. For example, primary astrocytes exposed to hypotonic media undergo a rapid initial 
swelling followed by regulatory volume decrease that depended on extracellular calcium influx 
(O'Connor and Kimelberg, 1993). An exhaustive review of the overlapping nature and of 
osmotic balance, heat shock and ion handling was outside the scope of this study. 
 
O-Glycosylation and glucose level 
Dysregulation of O-GlcNAc and aberrant O-GlcNAc modification has been implicated in 
pathologies of metabolic and neurodegenerative diseases as well as cancers and autoimmunity 
(Lefebvre et al., 2005). The Golgi has been identified as a target of O-GlcNAcylation during 
physiological growth conditions (Zhang et al., 2018). During starvation de-O-GlcNAcylated 
GRASP55 functions in linking LC3-II and LAMP2 to tether autophagosomes and lysosomes and 




Reactive Oxygen Species/Hypoxia 
All living cells are sensitive to reactive oxygen and reactive nitrogen species (ROS/RNS) from 
both exogenous and endogenous sources. The process of reducing oxygen in the electron 
transport chain produces an endogenous source of ROS, a serious threat, predominantly in the 
forms of superoxide and the hydroxyl radical. The predominant exogenous source of ROS is 
hydrogen peroxide (H2O2). H2O2 reagent is commonly used to introduce ROS to cells, since 
other molecular oxygen species cannot penetrate the plasma membrane.  
 
Several mechanisms of ROS scavenging exist within the cell to mitigate direct damage to 
biological tissues including glutathione, polyphosphate, vitamin C, etc. The mitochondria is 
typically credited as the major producer of ROS, but the Golgi apparatus is proposed to respond 
and play a key regulatory role in cellular responses to oxidative stress (Schieber and Chandel, 
2014).  
 
Hypoxic conditions result when mutated or damaged respiration enzymes and transporters 
interrupts the flow of oxygen and CO2 to and from tissues, starving them of energy via the loss 
of oxygen as a terminal electron acceptor in the electron transport chain. One pathway resulting 
from hypoxic condition is the unfolded protein response (UPR). Oxidized proteins cannot fold 
properly and leads to the onset of UPR. Accumulation of misfolded proteins and proteostasis is a 




It is generally believed degradation of damaged proteins and organelles is handled by the 
ubiquitin-proteasome or autophagy/lysosome pathways. Hypoxic conditions also interact with 
lipid metabolism increasing glycolysis with a decrease in gluconeogenesis, and dysregulates lipid 
stores (Bailey et al., 2015).  
 
In Chapter III a situation in the cell will be explored, where Golgi cisternae become lost when 
exposed to H2O2. Under these conditions, H2O2 treatment of HeLa cells reduces the number of 
Golgi cisternae, leading to the loss of Golgi tethers. Of further interest (and not covered here) 
would be to check whether Golgi tethers are also proteolytically degraded in hypoxic conditions.  
 
1.2.3 Key regulators of Golgi stress: GRASPs and beyond 
There are several cases of Golgi fragmentation in cells and a few cases have fairly well-known 
mechanisms. The mechanism for Golgi fragmentation during apoptosis for example is mediated 
by cleavage of Golgi matrix components by caspases. Some examples of matrix components that 
are cleaved in this way are GRASP65, Golgin 160, and p115. Depleting a golgin often causes 
fragmentation. 
 
As previously reported, during cell cycle progression, the Golgi also disassembles, releasing 
membranes that partition into each daughter cell (Fig. 1.6A). Mitotic Golgi disassembly is 
characterized by three stereotyped changes to the Golgi structure:  
1. Ribbon unlinking  
2. Cisternal unstacking  
3. Vesicle release 
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GRASP55 and GRASP65 are peripheral membrane proteins that organize the Golgi structure 
through GRASP domain oligomerization, and localize to the medial-trans and cis-Golgi 
cisternae, respectively. The GRASP region has been predicted to contain two hydrophobic 
protein-protein interaction modules called PDZ domains. Unstacking of cisternae is accompanied 
by the phosphorylation of GRASP55 and GRASP65 at the C-terminal serine/proline rich (SPR) 
domain by mitotic kinase (Fig. 1.6B). Phosphorylation destabilizes PDZ-mediated 
oligomerization. During interphase, the Golgi structure is also maintained by GRASPs. 
Knockdown of GRASPs by RNA-interference (RNAi) is followed by complete Golgi 
fragmentation and unstacking of the entire Golgi stack. Knockdown also leads to disruption of 
protein trafficking, modification and sorting (Xiang et al., 2013).  
 
Since GRASP55 and GRASP65 organize the Golgi structure, the dynamic Golgi regulation of 
GRASPs during interphase might provide a link between disruptions of Golgi structure and 
defects in trafficking, sorting and incomplete protein processing in disease. 
 
1.3 Tools to study Golgi stress 
There are many reagents that can be used in the lab as tools to study the effects that stress will 
have on cells. For example treatment of HeLa cells with Monensin hydrochloride solutions, leads 
to vacuolation of the Golgi apparatus, and a total block in anterograde trafficking. Disturbance of 
tobacco BY-2 cells with macrolide antibiotics, Concanamycin and Bafilomycin A1, which block 
V-ATPase, leads to a similar swelling phenotype and dysregulation of Golgi function. Upon 
Brefeldin A (BFA) treatment the Golgi apparatus collapses into ER. Upon washout of BFA, the 
exit of newly synthesized membrane proteins from the ER cisterna to the Golgi complex can 
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then be measured. Temperature-blocking cells (incubated at 20°C) prevents exit from the TGN, 
and accumulates cargo at the blocked Golgi. Reduced temperature from physiological ranges 
prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal 
glycosylation. After returning cells to 37°C, trafficking returns to normal. 
 
Many other tools to study the functions of the Golgi apparatus during Golgi stress will be 
discussed in following chapters. 
 
1.3.1 Golgi fragmentation 
Golgi stresses do not all produce the same effects on cells. However, the Golgi structure is 
frequently altered during cellular stresses on a temporary basis. One major alteration, called 
Golgi fragmentation, is the dissolution of the Golgi membranes into smaller components.  
 
Many cellular stresses result in Golgi fragmentation in cell culture. There are a number of stress-
induced Golgi structural phenotypes, including compacted and swollen, but one of the most 
common ones is fragmentation. Many cellular treatments result in Golgi fragmentation in cell 
culture including but not limited to viral infection, perturbations of cellular pH, and heat-shock.  
 
One advantage of using the Golgi fragmentation as an indicator of Golgi stress is that it has also 
been observed during human disease. Since the structure of the Golgi is closely linked to cellular 
functions during disassembly, Golgi fragmentation might have consequences for cellular 
functioning during disease. Yet studies have not established a specific, mechanistic description 
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of the molecular changes that alter the Golgi during many stresses, or made a direct connection 
between drug-induced fragmentation in cell culture and disease.  
 
Using optical approaches in tissue culture cells, this study explored the link between cellular stress 
and Golgi fragmentation, and investigated the mechanism and consequences of 
pharmacologically-induced Golgi structural changes. The hypothesis was: Golgi structure and 
functions are altered by Golgi stress (Fig. 1.7).  
 
In order to undertake the present study, a reliable approach to quantify the Golgi fragmentation 
phenotype quickly and consistently was needed. In order to quantify Golgi fragmentation, an 
unbiased approach that could be used to define whether a Golgi is intact or fragmented was 
developed.  Three hundred cells from each experiment was determined to be a sufficient number 
to get minimal variation within each experimental unit. First, cells were fixed and labeled for Golgi 
structural proteins of choice, and DNA. Then, slides were viewed under the microscope with a cell 
counter, using the following criteria: 
1) If the Golgi exists as a single piece of connected membrane, it is counted as intact.  
2) If a Golgi exhibits several items that are connected by visible membrane bridges, 
even though these bridges might be faint, the Golgi is considered intact.  
3) If a Golgi exhibits ≥ 3 disconnected pieces (no visible bridges connecting them), then 
the Golgi is fragmented.  
4) Mitotic cells, defined by the DNA pattern, and overlapping cells in which the Golgi 
pattern is difficult to define, are not counted. Hoechst was used to identify individual, 




1.3.2 Golgi stacking and EM 
Golgi stress and fragmentation was also defined using a more high resolution approach, since it 
was known that sometimes the Golgi became enlarged or compacted during some stress 
conditions, but light microscopy did provide much information about these phenotypes.  
 
Regular fluorescence has a resolution limit of 200 nanometers. The space between Golgi 
cisternae is about 8 nanometers. Since routine transmission electron microscopy has the ability to 
resolve structures down to the 0.2 nanometers, we chose this methodology as a better choice to 
examine Golgi fragmentation in greater detail.  
 
A methodology for examining Golgi ultrastructure was developed. Cells were stressed in cell 
culture and processed for electron microscopy (refer to methods section Chapters II and III). 
Golgi images were then captured at 11,000x magnification. Golgi morphology was quantified 
from at least 20 cells in each experiment for statistical robustness. A Golgi cisterna was 
identified as a perinuclear membrane within a Golgi stack ≥4 times longer than its width. After 
measurement of many different variables of Golgi stacks, the following three metrics were 
settled upon for providing the most information in stress conditions: 
 
1) Stack length - the longest cisterna within a Golgi stack, using the ruler tool in 
Photoshop Elements 13, was measured not accounting for bends or turns. 
2) Number of cisternae per stack - the number of cisternae per Golgi stack was counted. 
Closely associated ER-cisternae were omitted. 
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3) Number of vesicles per stack - round objects no greater than 80 microns in diameter 
within 0.5 micron distance to a Golgi stack were counted.  
 
1.3.3 Golgi functions during stress 
Many diseases and stresses affecting the Golgi apparatus are tied to impairment of Golgi 
functions. Familial amyotrophic lateral sclerosis or fALS transgenic mouse model of fALS 
(human SOD1-G93A) displayed shortened and fewer cisternae in spinal cord motor neuronal 
Golgi (Fig. 1.4B) (Mourelatos et al., 1996). Golgi fragmented several months prior to symptoms 
of ALS paralysis. No vesicles present around the shortened stacks suggested a loss of function. 
Golgi fragmentation is a result of microtubule depolymerization. A significant decrease in 
synaptic transmission has been reported in animals treated with microtubule depolymerizing 
drugs that disperse the Golgi apparatus. In neurons, many neurotransmitters are processed in the 
Golgi. Therefore, Golgi stress and fragmentation in ALS might cause impairment of neuronal 
function of axonal transport and synaptic vesicle release. 
 
Knockdown of GRASPs by RNA-interference (RNAi) is followed by complete Golgi 
fragmentation and unstacking of the entire Golgi stack. Knockdown also leads to disruption of 
protein trafficking, modification and sorting. Since GRASP55 and GRASP65 organize the Golgi 
structure, the dynamic Golgi regulation of GRASPs during interphase might provide a link 
between disruptions of Golgi structure and defects in trafficking, sorting and incomplete protein 
processing in disease. The regulation of Golgi structural proteins, such as GRASP55 and 
GRASP65, during interphase gives a plausible explanation for Golgi fragmentation during 
cellular stress. The extent of a Golgi stress response during TG and H2O2 treatment was studied 
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by evaluating the Golgi structure after stimulation. The evaluation identified whether GRASP55 
and GRASP65 were post-translationally modified by phosphorylation or other modifications 
during TG or H2O2 treatment, and confirmed the identity of changes that happened during stress. 
 
1.3.4 Calcium sensors 
Ca2+ dynamic at the Golgi as well as its role in membrane trafficking at the Golgi is still an 
understudied area. It’s been postulated that the Golgi apparatus might sense cellular stress. If 
aspects of the Golgi structure are specifically regulated during stress via calcium fluctuations, 
these changes might significantly impact Golgi functions. Several cellular organelles, like the ER 
and lysosomes, have inherent mechanisms to adapt their structure to accommodate stressful 
conditions and help maintain their specific functions.  
 
During ER stress, the ER-localized transmembrane protein pATF6, is transported to the Golgi 
where it is cleaved, at which point its cytosolic domain is translocated into the nucleus where it 
transcriptionally activates ER chaperone genes. There are now available reagents to detect ER 
stress such as antibodies that recognize the phosphorylated form of eIF2α and translational arrest 
that occurs during UPR. During starvation, the dephosphorylated transcription factor EB (TFEB) 
enters the nucleus and activates genes related to lysosomal degradation and autophagy. There are 
tools available to detect the activated autophagy pathway, most notably the antibody which 
recognizes LC3-I and LC3-II. By examining the ratio of LC3-II and LC3-I one can easily 




During this study calcium, too, was discovered to play a profound role in Golgi structure 
regulation. Changes affecting calcium also accompany the regulation of at least one Golgi 
structural protein, GRASP55, during interphase. Since it is known that this mechanism depends 
on calcium a calcium sensing version of GRASP55 was generated that can be reliably used to 
detect Golgi stress. The GRASP55 calcium probe utilizes a GCaMP sensor domain that enables a 
researcher to observe calcium flux as a function of fluorescent output. Using this calcium sensor, 
careful measurement of the extent of a Golgi stress response during diverse drug or 
environmental treatments can aid in the evaluation of drugs that may mitigate Golgi structure 
changes during stress. In essence this is a tool that can be used to directly measure Golgi stress in 
cells.  
 
1.4 The goal of this study 
The experiments and findings, presented herein, were designed to show whether or not the Golgi 
may be equipped to respond to cellular stress. Having a working understanding of the regulation 
of the Golgi apparatus during stress might result in discovery of ways to change and improve 







Fig. 1.1 The exocytic and endocytic trafficking network 
Cargo manufactured in the ER is loaded into COPII vesicles and sent to the Golgi via the 
intermediate compartment (IC). Upon arrival to the Golgi, vesicles fuse, forming the cis-Golgi 
Network. Cargo then progressively moves to the trans-Golgi Network. There, it is sorted and 
trafficked to many destinations such as endosomes (End), lysosomes (Lys), plasma membrane 





Fig. 1.2 Normal Golgi structure and position 
Schematic representation of single mammalian epithelial cell indicating the Golgi apparatus in 





Fig. 1.3 Golgi function and significance 
(A) Schematic representation of the cell indicating the Golgi apparatus in normal conditions (left 
side) and during a disruption of the Golgi stack (right side). (B) The net effect of fragmented 
Golgi is an increased membrane surface area for vesicle budding machinery to gain access. (C) 
The function of the cell that is altered is faster trafficking, sorting and glycosylation defects via 





Fig. 1.4 Disease and cellular stresses disrupt Golgi structure 
(A-B) Mourelatos, et al. show that ALS disease model mice having G93A mutation in the SOD1 
gene have disrupted Golgi structure (Mourelatos et al., 1996). Mouse spinal cord motor neuron 
Golgi apparatus showing WT Golgi in A, or ALS transgenic Golgi in B. MG-160 was the marker 
used. (C-D) Thayer et al. show that the Golgi fragments under hyper-excited conditions (Thayer 
et al., 2013). Neurons were cultured under normal (C) and overactivated (D) conditions (elevated 
potassium concentration, high potassium). Immunostaining (left) for GM130 (green) and MAP2 
(blue) with 3D reconstruction of anti-GM130 signal (right). The color of the distinct Golgi 
fragments corresponds to the relative size of the fragment. Scale bar, 10 microns. (E-F) 
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Quantification of number (#), and surface area (μm2) of distinct Golgi fragments from 





Fig. 1.5 Tools to study Golgi stress in cell culture 
(A) Figure shows seven categories of cellular stress and whether they cause Golgi fragmentation 
in HeLa cells. (B) HeLa cells treated with DMSO, (C) 1 mM H2O2 for 10 minutes, (D) 250 nM  
thapsigargin for 1 hour, or (E) 2 µM ionomycin for 1 hour. Cells were fixed and stained for 
Giantin (green), TGN46 (red), and Hoechst (blue). Asterisks (*) denote fragmented Golgi. Scale 





Fig. 1.6 Regulation of the Golgi stack structure 
(A) Golgi structure is diffused during mitosis. NRK cells were fluorescently labeled for 
antibodies against GM130 (green), tubulin (red), and DNA (blue) . Scale bar, 10 microns. (B) 





Fig. 1.7 Schematic approach for identifying mechanisms of Golgi stress response and 
dysfunction 
How certain hallmarks of Golgi stress, including Golgi fragmentation and cisternal unstacking, 
regulate many aspects of membrane trafficking is unknown. It remains to be resolved how Golgi 


















It has been well documented that the endoplasmic reticulum (ER) responds to cellular stresses 
through the unfolded protein response (UPR), but it is unknown how the Golgi apparatus 
responds to similar stresses. In this study, we treated HeLa cells with ER stress inducers, 
thapsigargin (TG), tunicamycin (Tm) and Dithiothreitol (DTT), and found that only TG 
treatment resulted in Golgi fragmentation. TG induced Golgi fragmentation at a low dose and 
short time when UPR was undetectable, suggesting that Golgi fragmentation occurs 
independently of ER stress. Further experiments demonstrated that TG induces Golgi 
fragmentation through elevating intracellular Ca2+ and protein kinase Cα (PKCα) activity, which 
phosphorylates the Golgi stacking protein GRASP55. Significantly, activation of PKCα with 




2 This chapter was modified from a version published the journal iScience, with authors listed as 
Stephen Ireland, Saiprasad Ramnarayanan, Mingzhou Fu, Xiaoyan Zhang, Jianchao Zhang, Jie 
Li, Dabel Emebo and Yanzhuang Wang (see Acknowledgments section). 
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histamine, modulates the Golgi structure in a similar fashion. Hence, our study revealed a novel 
mechanism through which increased cytosolic Ca2+ modulates Golgi structure and function. 
 
2.2 Introduction 
In mammalian cells, the Golgi apparatus is characterized by a multilayer stacked structure of ~5-
7 flattened cisternal membranes, and stacks are often laterally linked to form a ribbon located in 
the perinuclear region of the cell (Tang and Wang, 2013; Wang and Seemann, 2011). The exact 
mechanism of Golgi stack formation is not fully understood, but it has been shown that the Golgi 
re-assembly stacking protein of 55 kDa (GRASP55, also called GORASP2) and its homolog 
GRASP65 (GORASP1) play essential roles in Golgi stacking (Wang et al., 2003; Zhang and 
Wang, 2015). Both GRASPs are peripheral membrane proteins that share similar domain 
structures and overlapping functions (Wang and Seemann, 2011). GRASP65 is predominantly 
concentrated in the cis Golgi, whereas GRASP55 is localized on medial-trans cisternae. Both 
GRASPs form trans-oligomers through their N-terminal GRASP domains that “glue” adjacent 
Golgi cisternae together into stacks (Wang et al., 2003; Xiang and Wang, 2010) and ribbons 
(Feinstein and Linstedt, 2008; Puthenveedu et al., 2006). GRASP oligomerization is regulated by 
phosphorylation; mitotic phosphorylation of GRASP55 and GRASP65 at the C-terminal Serine/ 
Proline-Rich (SPR) domain inhibits oligomerization and results in Golgi cisternal unstacking and 
disassembly (Tang et al., 2012; Wang et al., 2005; Xiang and Wang, 2010).  
 
The Golgi exhibits different morphology in different cell types and tissues as well as under 
different conditions. For example, in many secretory cells such as Brunner's gland of platypus, 
the Golgi forms large, well-formed stacks (Krause, 2000), while electron micrographs show 
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reorganization of Golgi membranes in prolactin cells of female rats upon cessation of a sucking 
stimulus (Rambourg et al., 1993). In neurons, increased neuronal activity causes dispersal of the 
Golgi at the resolution of light microscopy (Thayer et al., 2013). In Alzheimer’s disease, the 
Golgi membranes are dispersed and fragmented in neurons from human brain and mouse models 
(Joshi et al., 2015). Golgi fragmentation is also observed in other neurodegenerative diseases, 
including Parkinson’s (Mizuno et al., 2001) and Huntington’s (Hilditch-Maguire et al., 2000) 
diseases and amyotrophic lateral sclerosis (ALS) (Fujita and Okamoto, 2005; Gonatas et al., 
1998; Mourelatos et al., 1996). In addition, the Golgi has also been shown to be fragmented in 
lung, prostate and breast cancers (Petrosyan et al., 2014; Sewell et al., 2006; Tan et al., 2016). A 
plausible hypothesis is that the Golgi adjusts its structure and function in response to different 
physiological and pathological conditions; however, the molecular mechanisms that control 
Golgi structure and function under disease conditions are so far not well understood. 
 
The Golgi structure can be modulated experimentally such as by molecular manipulations of 
GRASP55 and GRASP65. Microinjection of antibodies against GRASP55 or GRASP65 into 
cells inhibits post-mitotic stacking of newly formed Golgi cisternae (Wang et al., 2003; Wang et 
al., 2008). Knockdown (KD, by siRNA) or knockout (KO, by CRISPR/Cas9) of either GRASP 
reduces the number of cisternae per stack (Sutterlin et al., 2005; Tang et al., 2010b), whereas 
simultaneous depletion of both GRASPs causes fragmentation of the entire Golgi stack (Bekier 
et al., 2017; Xiang and Wang, 2010). Expression of non-phosphorylatable GRASP65 mutants 
enhances Golgi stacking in interphase and inhibited Golgi disassembly in mitosis (Tang et al., 
2010b). Since GRASPs play critical roles in Golgi structure formation, it is reasonable to 
speculate that physiological and pathological cues may trigger Golgi fragmentation through 
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GRASP55/65 modification, such as phosphorylation (Ahat et al., 2019a; Li et al., 2019a). Using 
GRASPs as tools to manipulate Golgi stack formation, it has been demonstrated that Golgi 
cisternal unstacking accelerates protein trafficking but impairs accurate glycosylation and sorting 
(Bekier et al., 2017; Xiang et al., 2013). In addition, GRASP depletion also impacts other 
cellular activities such as cell attachment, migration, growth, and autophagy (Ahat et al., 2019b; 
Zhang et al., 2019; Zhang et al., 2018). 
 
Protein kinase C (PKC) is a large family of multifunctional serine/threonine kinases that are 
activated by signals such as increases in the concentration of diacylglycerol (DAG) and/or 
intracellular calcium ions (Ca2+). In cells, PKCs are mainly cytosolic, but transiently localize to 
membranes such as endosomes and Golgi upon activation (Chen et al., 2004; El Homasany et al., 
2005). Membrane association of PKC is via a C1 domain that interacts with DAG in the 
membrane. Conventional PKCs (cPKCs) also contain a C2 domain that binds Ca2+ ions, which 
further enhances their membrane association and activity (Nishizuka, 1995). Knockdown of 
atypical PKCs (aPKCs) using siRNA causes a reduction in peripheral ERGIC-53 clusters without 
affecting the Golgi morphology (Farhan et al., 2010). In addition, increased PKC activity has 
been implicated in cancer (Cooke et al., 2017; Kim et al., 2013), but the mechanism by which 
PKC may contribute to invasion, inflammation, tumorigenesis, and metastasis is not fully 
understood (Griner and Kazanietz, 2007).  
 
In this study, we performed high-resolution microscopy and biochemistry experiments to 
determine how the Golgi responds to cellular stresses such as ER stress. While not all ER stress 
inducers caused Golgi fragmentation, treatment of cells with the Ca2+-ATPase inhibitor 
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thapsigargin (TG) resulted in Golgi fragmentation with a low dose and short time in which ER 
stress was undetectable, indicating that Golgi fragmentation occurs independently of ER stress. 
Further experiments demonstrated that TG-induced cytosolic Ca2+ spikes activate PKC that 
phosphorylates GRASP55. Interestingly, inflammatory factors such as histamine modulate the 
Golgi structure through a similar mechanism. Thus, we have uncovered a novel pathway through 
which cytosolic Ca2+ modulates the Golgi structure and function.  
 
2.3 Results 
2.3.1 TG treatment induces Golgi fragmentation and UPR 
It has been hypothesized that ER stress and the unfolded protein response (UPR) cause Golgi 
fragmentation and dysfunction through overloading misfolded proteins into the Golgi (Oku et al., 
2011). To test this hypothesis, we performed a time course treatment of HeLa cells with a well-
known UPR inducer, TG, which specifically blocks the sarcoendoplasmic reticulum Ca2+ 
transport ATPase (SERCA) (Xu et al., 2004) and causes Ca2+ dysregulation (Ito et al., 2014). We 
assessed the Golgi morphology by co-staining the cells for GM130, a cis-Golgi marker, and 
TGN46, a protein in the trans-Golgi network. As shown in Fig. 2.1A-B, the Golgi became 
fragmented after TG treatment, and the response was linear over time (Fig. 2.1A-B). Although 
Golgi fragmentation was more obvious after a longer treatment, it became detectable in shorter 
treatments such as 10 min. We also performed super-resolution microscopy to examine the Golgi 
structure in parallel after Tm, DTT or TG treatment. Similar to that observed in control cells, the 
Golgi structure is intact in Tm and DTT-treated cells, with extensive overlap between cis- and 
trans-Golgi markers; whereas TG treatment caused not only fragmentation of the Golgi 
structure, but also separation of cis- and trans-Golgi markers (Fig. 2.1C-D). This careful 
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examination of the Golgi morphology by super-resolution fluorescence microscopy 
demonstrated that the Golgi ribbon was broken down, as the Golgi in TG treated cells appeared 
as disconnected puncta (Fig. 2.1C-D). 
 
To correlate Golgi fragmentation with UPR, we performed Western blot of TG-treated cells to 
assess the levels of several UPR markers, including phosphorylated eukaryotic translation 
initiation factor 2A eIF2α (p-eIF2α), the ER UPR chaperone binding of immunoglobulin protein 
(Bip), and the CCAAT-enhancer-binding protein homologous protein (CHOP). As shown in Fig. 
2.1E-G, longer term TG treatment, such as 2 h or longer, caused UPR, as indicated by the 
increase of all three markers. When the treatment was reduced to 30 min, only the p-eIF2α level 
increased, while Bip and CHOP did not change. This indicates that the minimal time for UPR to 
occur is ~30 min under our experimental conditions. Consistently, no significant increase in the 
level of any of these UPR markers was detected when the treatment was reduced to below 30 
min. Interestingly, the Golgi in a significant proportion of cells was fragmented at this time. 
Golgi fragmentation was obvious with 10 min TG treatment when UPR was undetectable, and 
became more prevalent at 30 min treatment (Fig. 2.1A-B). The fact that Golgi fragmentation 
occurs earlier than UPR indicates that Golgi fragmentation is unlikely a downstream effect of ER 
stress, but rather, occurs independently of UPR.  
 
It is worth mentioning that TG treatment did not affect the level of key Golgi structural proteins, 
including the Golgi stacking proteins GRASP55 and GRASP65, the Golgi tethering protein 
GM130, and the Golgi SNARE Gos28 (Fig. 2.1E), indicating that TG induces Golgi 
fragmentation likely through modification rather than degradation of Golgi structural proteins. 
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TG-induced Golgi fragmentation is reversible; when TG was washed out, the Golgi structure 
gradually returned to its normal shape (Fig. 2.2A-B). Consistently, TG-treatment did not induce 
apoptosis as shown by Annexin V staining. In contrast, staurosporine treatment, which is known 
to induce apoptosis, increased Annexin V cell surface staining (Fig. 2.2C-D). In addition, TG 
treatment did not seem to affect the organization of the actin and microtubule cytoskeleton (Fig. 
2.2E-F).  
 
2.3.2 Tunicamycin (Tm) or dithiothreitol (DTT) treatment induces UPR but not Golgi 
fragmentation 
To test whether the hypothesis that Golgi fragmentation occurs independently of UPR applies 
only to TG treatment or also to other ER stress inducers, we repeated the same set of experiments 
by treating cells with tunicamycin (Tm), an antibiotic that induces ER stress by inhibiting N-
glycosylation and the accumulation of misfolded proteins in the ER lumen. Tm treatment did not 
affect the Golgi morphology after 360 min, as indicated by the GM130 and TGN46 signals (Fig. 
2.3A-C). Further analysis of Tm-treated cells by electron microscopy (EM) also did not reveal 
any significant changes in the Golgi structure (Fig. 2.3D). The treatment indeed induced UPR, as 
indicated by the robust increase in the p-eIF2α, Bip and CHOP levels, in particular after 120 min 
(Fig. 2.3E-G). 6 h Tm treatment increased the width of the ER cisternae and caused ER 
fragmentation (Fig. 2.3H). Like Tm, dithiothreitol (DTT) treatment also did not cause Golgi 
fragmentation, although Bip and CHOP levels increased significantly after 120 min of treatment 





2.3.3 TG induces Golgi fragmentation prior to UPR through elevated cytosolic Ca2+ 
We next sought to decouple the Golgi stress response from UPR after TG treatment. As a 
complimentary approach to the time-course experiment shown in Fig. 2.1, we titrated TG (1 - 
250 nM) in the treatment. Here we treated cells for 20 min, a time point prior to UPR becoming 
detectable when cells were treated with 250 nM TG (Fig. 2.5). The results showed that Golgi 
fragmentation increased linearly in response to the increasing TG concentration, and importantly, 
TG at low doses (1 nM to 250 nM) effectively caused Golgi fragmentation (Fig. 2.5A-B). For 
comparison, we also assessed UPR in the same cells. As shown in Fig. 2.5C-E, treatment of cells 
with up to 250 nM TG for 20 minutes did not cause UPR as indicated by the p-eIF2α and Bip 
levels. These results indicate that TG-triggers Golgi fragmentation independent of ER stress.  
 
We next asked how TG treatment induces Golgi fragmentation. Knowing that TG increases 
cytosolic Ca2+ (Jones and Sharpe, 1994), we employed the membrane permeable Ca2+ chelater 
BAPTA-AM to test whether TG induces Golgi fragmentation through cytosolic Ca2+. We pre-
treated cells with BAPTA-AM alone (60 µM) for 30 min, and then with or without TG (100 nM) 
for 0, 15, 30, and 60 min (Fig. 2.5F-G). The result showed that BAPTA-AM significantly 
prevented TG-induced Golgi fragmentation, while BAPTA-AM alone did not affect the Golgi 
morphology. Subsequent EM analysis confirmed TG-induced Golgi fragmentation and its rescue 
by BAPTA-AM (Fig. 2.5H-I). TG treatment reduced the number of cisternae per stack and the 
length of cisternae, but increased the number of vesicles surrounding each stack. These effects 
were largely abolished by the addition of 60 µM BAPTA-AM for 30 minutes. Further testing of 
various concentrations of BAPTA-AM for 10 minutes could inhibit 250 nm TG treatment (Fig. 
2.6A-B). Furthermore, we carried out similar experiments in normal rat kidney (NRK) cells and 
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RAW 264.7 murine macrophages and obtained similar results (Fig. 2.7), indicating that the 
effect of TG treatment on the Golgi structure is not cell type specific. These results demonstrated 
that cytosolic Ca2+ is required for TG-induced Golgi fragmentation. Therefore, the driving force 
behind TG-induced Golgi fragmentation is the elevated cytosolic Ca2+. 
 
2.3.4 TG-induced Golgi fragmentation increases protein trafficking in the Golgi 
As GRASP depletion-mediated Golgi destruction impacts Golgi functions such as protein 
trafficking (Ahat et al., 2019b; Xiang et al., 2013), we examined the effect of TG treatment on 
the trafficking of the Vesicular Stomatitis Virus Glycoprotein (VSV-G) using the well-
established RUSH system (Boncompain et al., 2012). Cells were transfected with a plasmid that 
encodes both the invariant chain of the major histocompatibility complex (Ii, an ER protein) 
fused to core streptavidin and VSV-G fused to streptavidin-binding peptide (SBP). Under growth 
conditions without biotin, the interaction between streptavidin and SBP retains VSV-G in the 
ER. Upon the addition of biotin, this interaction is disrupted, resulting in synchronous release of 
the VSV-G reporter from the ER to the Golgi. Since VSV-G is a glycoprotein, we used 
endoglycosidase H (EndoH) to distinguish its core (ER and cis Golgi) and complex (trans Golgi 
and post-Golgi) glycosylation forms as an indicator of trafficking. As shown in Fig. 2.8A, TG 
treatment first slightly decreased VSV-G trafficking at 15 min release, but then increased VSV-G 
trafficking at 60 and 90 min compared to DMSO control. Our previous studies showed that 
VSV-G reaches the cis Golgi at 15-20 min and trans Golgi at ~90 min (Bekier et al., 2017; Li et 
al., 2019b). These results suggest that TG treatment may delay VSV-G release possibly by 
slowing down its folding; but once it reaches the cis Golgi, VSV-G trafficking across the Golgi 
stack is significantly accelerated. Monensin (Mo) is known to disrupt the Golgi structure and 
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blocks TGN exit (Fliesler and Basinger, 1987), and thus was used as a control. As expected, 
monensin treatment resulted in VSV-G accumulation in the Golgi (Fig. 2.8A-C).  
 
To confirm these results using an alternative approach, we treated cells with Brefeldin A (BFA) 
to accumulate ManII-GFP in the ER. We then washed out BFA and analyzed ManII-GFP in ER-
to-Golgi trafficking. The results showed that ManII-GFP started to accumulate in the Golgi at 60 
min of BFA washout in the presence of TG, while the same observation occurred at 90 min in 
the control (Fig. 2.8D). 
 
2.3.5 TG induces Golgi fragmentation through PKCα activation 
Given that phosphorylation of Golgi structural proteins has been shown to cause Golgi 
fragmentation in physiological conditions such as in mitosis (Tang et al., 2010b; Wang et al., 
2003; Xiang and Wang, 2010), as well as in pathological conditions such as in Alzheimer’s 
disease (Joshi et al., 2014), we explored the possibility that phosphorylation of Golgi structural 
proteins may play a role in TG-induced Golgi fragmentation. We treated cells with 
staurosporine, a non-selective kinase inhibitor, and a number of specific inhibitors of calcium-
related kinases such as protein kinase Cs (PKCs) and Ca2+/calmodulin-dependent protein kinases 
(CAMKs). As shown in Fig. 2.9A-B, staurosporine significantly reduced Golgi fragmentation in 
TG-treated cells. In addition, Bisindolylmaleimide I (BIM1), a selective PKC inhibitor, and KN-
93, an inhibitor of CAMKII, also partially reduced Golgi fragmentation in TG-treated cells (Fig. 
2.9A-B). These results suggest that either PKC and/or CAMKII is involved in TG-induced Golgi 
fragmentation. Since both BIM1 and KN-93 inhibitors have pleiotropic effects, we selected two 
alternative drugs, Gӧ6976 and KN-62, to inhibit PKC and CAMKII, respectively. While Gӧ6976 
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inhibited TG-induced Golgi fragmentation effectively, KN-62 had no effect (Fig. 2.9A-B), 
suggesting a major role of PKC in TG-induced Golgi fragmentation.  
 
To further confirm that PKC activation causes Golgi fragmentation, we treated cells with phorbol 
12-myristate 13-acetate (PMA), a widely used PKC activator, and its inactive enantiomer, 4-
alpha-phorbol myristate acetate (4-alpha). The results showed that 4-alpha had no effect on the 
Golgi structure, while PMA treatment caused Golgi fragmentation (Fig. 2.9C-D), although 4-
alpha and PMA had no effect on the level of PKC expression (Fig. 2.9E). Taken together, these 
results indicate that TG induces Golgi fragmentation through PKC activation.  
 
PKC has multiple isoforms including α, βI, βII, γ, δ, ε, η, ζ, and ι (Kajimoto et al., 2001). To 
identify the PKC isoform responsible for TG-induced Golgi fragmentation, we expressed GFP-
tagged PKC isoforms, including all four known classical PKC (cPKC) isoforms (α, βI, βII, γ) 
that respond to Ca2+ stimuli, one from the non-calcium responsive novel PKC (nPKC, δ), and 
one from the atypical PKC (nPKC, ζ) subfamily (Fig. 2.10A-B). To enhance the activity of 
expressed PKC, we also treated cells with PMA, using 4-alpha as a control. The results showed 
that expression of PKCα and treatment of cells with PMA increased Golgi fragmentation (Fig. 
2.10A-B, Fig. 2.11A-C). Interestingly, in addition to the localization to the plasma membrane as 
previously reported (Becker and Hannun, 2003), wild type PKCα-GFP was also concentrated on 
the Golgi upon PMA treatment, as indicated by the colocalization with GM130 (Fig. 2.11A; Fig. 
2.10B); while other PKC isoforms, or the inactive PKCα K368R mutant (Baier-Bitterlich et al., 




To further specify that PKCα mediates TG-induced Golgi fragmentation, we knocked down 
PKCα in cells with siRNA. The results showed that PKCα depletion reduces Golgi fragmentation 
after TG treatment (Fig. 2.11F-H). Taken together, these results demonstrate that PKCα 
activation causes Golgi fragmentation.  
 
2.3.6 PKCα induces Golgi fragmentation through GRASP55 phosphorylation 
Since activated PKCα localizes to the Golgi, we thought it might phosphorylate Golgi structural 
proteins. To identify potential PKCα targets on the Golgi, we performed gel mobility shift assays 
on a number of Golgi structural proteins, tethering factors, and SNARE proteins after TG 
treatment (Fig. 2.12A). To ensure that the band shift was caused by phosphorylation, we also 
applied staurosporine (2 µM for 10 min prior to TG treatment) to TG-treated cells to broadly 
inhibit phosphorylation. Among the proteins tested, GRASP55 and GRASP65 showed a smear 
above the main bands (Fig. 2.12A), indicating a partial phosphorylation of the proteins. To 
increase the resolution of phosphorylated proteins we utilized phos-tag gels, which showed 
GRASP55, but not GRASP65, to be significantly shifted up after TG treatment (250 nM, 1 h) 
(Fig. 2.12B). TG-induced mobility shift of GRASP55 was not seen upon Tm treatment (Fig. 
2.12C, lanes 2 vs. 3; Fig. 2.12D), and was less dramatic than by nocodazole (Noc) treatment that 
blocks cells in mitosis when GRASP55 is fully phosphorylated (Fig. 2.12C, lanes 3 vs. 4) 
(Xiang and Wang, 2010), indicating that TG induced partial phosphorylation of GRASP55. The 
mobility shift of GRASP55 triggered by TG treatment was abolished by the addition of 




To determine if PKCα could phosphorylate GRASP55 directly, recombinant GRASP55 was 
incubated with a small amount of active PKCα in vitro and products were run on phos-tag gel 
and Coomassie stained (Fig. 2.12E). The Coomassie stained band pattern revealed two p-
GRASP55 bands. We next increased the amount of PKCα in the reaction and incubated it with 
recombinant GRASP55. When Western blot was performed GRASP55 phosphorylation bands 
were confirmed showing that PKCα can directly phosphorylate GRASP55 (Fig. 2.12F, upper 
panel). In this experiment, PKCα was also auto-phosphorylated (Fig. 2.12F, lower panel). To 
identify the specific phosphorylation sites on GRASP55, a series of point mutants were  
constructed based on likely PKC consensus sites within the GRASP55 protein sequence: S255A, 
S260A, S262A/S263A, S269A, S273A/T274A, T278A, S289A, and S292A. These sites were 
assayed but none seemed to strongly abolish the GRASP55 mobility shift induced by PKC (data 
not shown). 
 
GRASP55 contains an N-terminal GRASP domain that forms dimers and oligomers, and a C-
terminal serine/proline-rich (SPR) domain with multiple phosphorylation sites (Xiang and Wang, 
2010; Zhang and Wang, 2015). To map the PKCα phosphorylation site on GRASP55, we 
expressed GFP-tagged GRASP55 truncation mutants (Zhang et al., 2018), treated the cells with 
TG, and determine their phosphorylation. A visible mobility shift of the GRASP55 variants was 
observed on the mutants possessing amino acids (aa)251-300, but not the truncated forms shorter 
than aa250 (Fig. 2.13A-B). To further determine the functional consequence of GRASP55 
phosphorylation, we expressed these constructs and treated cells with or without TG. The 
exogenously expressed GRASP55 truncation mutants were targeted to the Golgi as indicated by 
giantin as a Golgi marker, but had no impact on the Golgi structure (Fig. 2.13C). However, when 
44 
 
cells were treated with TG, expression of the N-terminal aa250 or shorter reduced TG-induced 
Golgi fragmentation; while expression of N-terminal aa300 or longer had no significant effect 
(Fig. 2.13C-D). These results demonstrated that phosphorylation of GRASP55 within aa251-300 
is important for TG-induced Golgi fragmentation. Taken together, these results demonstrate that 
TG treatment activates PKCα, which localizes to the Golgi membrane and subsequently 
phosphorylates GRASP55. 
 
2.3.7 Histamine modulates the Golgi structure 
It is known that histamine activates Ca2+-dependent PKC isoforms and up-regulates cytokine 
secretion via the release of calcium from the ER into the cytosol (Matsubara et al., 2005). It has 
also been shown that histamine triggers protein secretion and Golgi fragmentation (Saini et al., 
2010), but the underlying mechanism has not been revealed. Therefore, we treated HeLa cells 
with histamine and determined the effect on Golgi morphology. EM analysis confirmed that 
histamine treatment induced alterations in the Golgi structure at a concentration and time often 
used in previous studies (Sahoo et al., 2017; Xie et al., 2018) (Fig. 2.14). As shown in Fig. 
2.15A-B, histamine treatment induced Golgi fragmentation in a dose and time dependent 
manner. More than 40% of cells possessed fragmented Golgi after 100 µM histamine treatment 
for 1 h (Fig. 2.15B). Subsequent EM analysis confirmed that histamine treatment induced 
alterations in the Golgi structure including fewer cisternae per stack, shorter cisternae, and an 
increased number of Golgi-associated vesicles (Fig. 2.15C-D; Fig. 2.14) 
 
It has been previously shown that histamine activates Gβγ, which causes TGN fragmentation 
(Saini et al., 2010). Since HeLa cells do not express Gβγ, and histamine treatment triggers 
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fragmentation of the entire Golgi stack (Fig. 2.15C-D), the Golgi fragmentation observed in our 
study may occur through a different mechanism. Indeed, like TG, histamine-induced Golgi 
fragmentation also depended on PKC, as the addition of the PKC inhibitor Gӧ6976 reduced 
histamine-induced Golgi fragmentation (Fig. 2.15E-F). These results demonstrate that histamine 
treatment impacts Golgi structure through a similar mechanism as TG. 
 
While it has been well documented that TG or histamine treatment elevates Ca2+ level in the 
cytosol, whether this is also true for the Ca2+ level in the Golgi region has not been reported. To 
test the effect of TG or histamine treatment on the Ca2+ level in the Golgi region in real-time, we 
fused the Ca2+ probe GCaMP (Muto et al., 2013) to GRASP55, expressed the GRASP55-
GCaMP construct in cells (Fig. 2.15G), and performed live cell imaging. Treatment of cells with 
100 µM histamine caused a robust calcium spike (Fig. 2.15H). Subsequent experiments using 
this novel Golgi-localized Ca2+ probe demonstrated that treatment of cells with TG and Io also 
significantly elevated the Ca2+ level in the Golgi (Fig. 2.15I). Taken together, our results 
demonstrated that histamine or TG treatment elevates the Ca2+ level in the Golgi region, which 
subsequently activates PKCα, leading to GRASP55 phosphorylation and Golgi fragmentation 
(Fig. 2.16). Thus, this study revealed a novel mechanism of how histamine, and perhaps other 
drugs, modulates Golgi structure and function. 
 
2.4 Discussion 
In this study, by comparing Golgi fragmentation with ER stress in response to TG, Tm and DTT 
treatments, we uncovered a novel signaling pathway through which increased cytosolic Ca2+ 
triggers Golgi fragmentation through PKCα activation and GRASP55 phosphorylation. 
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Significantly, we also demonstrated that histamine modulates the Golgi structure via a similar 
mechanism, which opens a new window through which we can better understand the effect of 
histamine on cell physiology. 
 
One possible model of Golgi stress is that the expanding capacity of the ER during cellular stress 
leads to the failure of the Golgi as it is over-burdened with misfolded or improperly folded 
proteins, affecting its functions like glycosylation (Oku et al., 2011). However, our results do not 
support this hypothesis for two reasons: First, although three ER stress inducers, TG, Tm and 
DTT, all induce ER stress, only TG treatment causes Golgi fragmentation. Second, TG induces 
Golgi fragmentation at a low dose and time when UPR is undetectable. These results 
demonstrate that Golgi fragmentation occurs independently of ER stress; instead, the Golgi may 
possess its own mechanism to sense and respond to stress. Furthermore, our study revealed a 
novel mechanism that coordinates Golgi structure and perhaps function: TG treatment increases 
cytoplasmic Ca2+, which activates PKCα, that subsequently phosphorylates GRASP55, impairing 
its function in Golgi structure formation. GRASP55 therefore provides the conceptual link 
between an extracellular cue and Golgi morphological change during stress. 
 
GRASP55 is comprised of an N-terminal GRASP domain (aa1-212) that forms dimers and 
oligomers and functions as a membrane tether to maintain an intact Golgi structure, and an SPR 
domain (aa212-454) that undergoes post-translational modifications and functions as the 
regulatory domain of the protein (Xiang and Wang, 2010; Zhang and Wang, 2015). Originally, 
GRASP55 was found to be phosphorylated by ERK2 at T225 and T222 (Jesch et al., 2001). 
Subsequently, additional sites, such as S245 and T249, were identified to be phosphorylated in 
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mitosis, which is required for mitotic Golgi disassembly (Xiang and Wang, 2010). Recently, 
GRASP55 was discovered to be de-O-GlcNAcylated upon energy or nutrient deprivation and 
regulates autophagosome maturation (Zhang et al., 2019; Zhang et al., 2018). These results 
indicate that GRASP55 is an excellent candidate to function as both a sensor and effector of 
cellular stresses. Thus, GRASP55 is likely a master regulator of Golgi structure formation, 
function, and stress responses.  
 
Our in vitro phosphorylation assay demonstrated that PKCα can directly phosphorylate 
GRASP55 likely on more than one site. Previously, it has been shown by mass spectrometry that 
GRASP55 is phosphorylated on S441 after TG treatment, but the kinase mediating this 
phosphorylation is unknown (Gee et al., 2011). Although our results are consistent with this 
previous study, the exact phosphorylation site(s) need further investigation. 
 
Histamine is a neuroendocrine hormone involved in the regulation of stomach acid secretion, 
brain function and immune response; many of these functions involve secretion (Karpati et al., 
2018; Sahoo et al., 2017; Xie et al., 2018). The role of histamine in immune response is often 
through the activation of the downstream kinase PKCα. For example, histamine enhances the 
secretion of granulocyte-macrophage colony stimulation factor (GM-CSF) and nerve growth 
factor (NGF) in different cell types, both through a PKCα-dependent mechanism (Sohen et al., 
2001). Interestingly, histamine promotes HeLa cell proliferation and growth, and has been shown 
to be elevated in cancers where Golgi is fragmented and secretion is enhanced. Histamine does 
not induce ER stress (Deniaud et al., 2008). In our experiments, histamine induced a clear Golgi 
fragmentation phenotype, confirming a link between histamine and Golgi fragmentation. 
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Additionally, expression of PKCα, but not other PKC isoforms, along with a stimulation with 
PMA, exhibited an additive Golgi fragmentation effect. Interpreting results of drug treatments 
used in this study present problems, and this was mitigated by using minimum doses consistent 
with those found in literature, or even less in the case of thapsigargin. Consistent with prior work 
showing that disassembly of Golgi stacks accelerates protein trafficking (Xiang et al., 2013), our 
findings therefore offer a mechanism for how histamine increases secretion of inflammatory 
factors. 
 
How Ca2+ controls membrane trafficking at the plasma membrane has been well documented in 
regulated secretion in specific cell types such as neurons, neuroendocrine cells and mast cells; 
while its role in other cell types is less well known. Ca2+ dynamic at the Golgi as well as its role 
in membrane trafficking at the Golgi is still an understudied area. There are EF-hand Ca2+ 
binding proteins associated in the Golgi. For example, Cab45 is located in the Golgi lumen, 
while Calnuc is found in both cell cytosol and membrane fractions (Lin et al., 1998). At the cis-
Golgi, Calnuc binds Gαi and Gαs, which is thought to be important for vesicular trafficking (Lin 
et al., 2000). There are also P-Type ATPases (SPCAs) such as SPCA1 located in the Golgi that 
regulate Ca2+ homeostasis in the Golgi and control neural polarity (Sepulveda et al., 2009; 
Vanoevelen et al., 2007). Our study provided a novel link between thapsigargin and histamine 
treatment, elevation of Ca2+ concentration in the Golgi region, activation of PKC and 
phosphorylation of Golgi GRASP55, and modification of Golgi structure and function.  
 
Our study revealed that TG induces Golgi fragmentation through increasing cytosolic Ca2+ and 
GRASP55 phosphorylation. A similar case has been described previously in Alzheimer's disease, 
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where cytosolic calcium increases by Aβ treatment triggers activation of a cytosolic protease, 
calpain, which cleaves p35 to generate p25 and activate Cdk5, a cytoplasmic kinase that is highly 
expressed in neurons (Lew et al., 1994). Subsequently, activated Cdk5 phosphorylates GRASP65 
and perhaps other Golgi structural proteins, leading to Golgi fragmentation (Joshi et al., 2015; 
Joshi et al., 2014). Although PKC and GRASP55 were not the focus in this study, expression of 
a phosphorylation deficient mutant of GRASP55 significantly reduced Golgi fragmentation as 
well as Aβ production. Taken together, our studies indicate that the Golgi is sensitive to cellular 
stimuli and stresses as in disease conditions, and responds to signaling cues to adjust its structure 
and function through increasing cytosolic Ca2+ and GRASP55 modification. Future studies 
defining the detailed mechanisms may help understand disease pathologies with Golgi and 
trafficking defects.  
 
2.5 Materials and Methods 
Reagents, Plasmids and siRNA 
All reagents used were from Sigma-Aldrich (St. Louis, MO), Roche (Basel, Switzerland) or 
Calbiochem (EMD Millipore, Burlington, MA), unless otherwise stated. The Annexin V 
apoptosis detection kit was from BioVision Inc. (San Francisco, CA). PKCα-GFP and GFP-
PKCβII plasmids were provided by Dr. Yusuf Hannun (Stony Brook Cancer Center). GFP-
PKCβI, GFP-PKCδ, and GFP-PKCζ plasmids were provided by Dr. Hesham El-Shewy (Medical 
University of South Carolina). The CAMKIIβ plasmid was provided by Dr. Mohammed 
Akaaboune (University of Michigan). The Str-li_VSVGwt-SBP-EGFP plasmid was provided by 
Dr. Franck Perez (Institut Curie). PKCγ-GFP cDNA construct was purchased from Addgene 
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(Cambridge, MA). The ManII-GFP HeLa cell line was made in house by transfecting HeLa cells 
with α-mannosidase II covalently linked to GFP. 
 
Control siRNA (Silencer Select Negative Control #1 siRNA) was purchased from Applied 
Biosystems (ThermoFisher). PKC-specific custom siRNA targeting to endogenous human PKCα 
(5’-CAGAAGAACTGTATGCAAT-3’) was purchased from Ambien (ThermoFisher). To 
perform knockdowns, 200 nM of each oligo was used to transfect cells for 48 hours.  
 
Antibodies 
The following antibodies were used: monoclonal antibodies against β-actin and GFP (Sigma-
Aldrich), Gos28 and GM130 (BD Biosciences, Franklin Lanes, NJ), PKCα (Santa Cruz 
Biotechnology, Dallas, TX), and -tubulin (Developmental Studies Hybridoma Bank, University 
of Iowa); polyclonal antibodies against CHOP, p-eIF2, eIF2 and p115 (Cell Signaling, 
Danvers, MA), Giantin, GRASP55 and GRASP65 (Proteintech), Bip (Santa Cruz), GM130 
("N73" from Dr. J. Seemann), and TGN46 (Bio-Rad). Secondary antibodies were purchased 
from Jackson Laboratory (Bar Harbor, ME). Secondary antibodies used for fluorescence 
microscopy include fluorescence-labelled goat anti-mouse, goat anti-rabbit and goat anti-sheep 
(for TGN46) antibodies, all used in 1:200 dilution. Secondary antibodies used for Western blot 
include HRP-conjugated goat anti-mouse and goat anti-rabbit antibodies, all used in 1:5000 
dilution. 
 
Cell Culture and Drug Treatments  
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For all experiments, mycoplasma-free HeLa were obtained from ATCC (Manassas, VA) and 
passaged ≤20 times prior to use in experiments. NRK cells were a gift from Dr. Peter Arvan 
(University of Michigan). HeLa and NRK cells were cultured in Dulbecco's modified Eagle’s 
medium (DMEM; ThermoFisher, Waltham, MA) supplemented with 10% fetal bovine serum 
(FBS; Gemini Bio-Products, Sacramento, CA) and 100 units/ml penicillin-streptomycin at 37°C 
with 5% CO2. RAW 264.7 murine macrophages were kindly provided by Dr. Kezhong Zhang 
(Wayne State University) and cultured in RPMI 1640 medium supplemented with 10% fetal 
bovine serum and 100 units/ml penicillin-streptomycin at 37°C with 5% CO2. Cells were grown 
on glass coverslips according to standard tissue culture methods (Tang et al., 2012). Coverslips 
were pre-coated with poly-lysine (Gibco) to aid in cell attachment. For mitotic synchronization, 
cells were treated with 100 ng/ml nocodazole for 18 h and "shake-off" cells (Xiang et al., 2007) 
were collected and lysed for Western blot analysis. All drugs, except cAMP-dependent protein 
kinase inhibitor (PKI) that is a peptide and dissolved in water, were made in DMSO, aliquoted, 
and stored at -20ºC. Stocks were diluted into working solutions of DMEM at the time of the 
experiment as described in the text or figure legend. Upon the addition of the drug, cells were 
incubated at 5% CO2 and 37°C for the indicated times. Cells were washed 3 times with ice cold 
phosphate buffered saline (PBS) and collected with a cell scraper. 
 
Immunofluorescence Microscopy 
For fluorescence microscopy, cells were rinsed 3 times in ice cold PBS, fixed with 4% (w/v) 
paraformaldehyde, quenched with 50 mM NH4Cl, permeabilized in 0.2% v/v Triton X-100 in 
PBS, and blocked for 1 h with PBS with 1% w/v bovine serum albumin (BSA) Fraction V 
(ThermoFisher, Waltham, MA) (Tang et al., 2016). Cells were incubated with a primary 
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antibody diluted in 1% BSA in PBS (PBSB) at room temperature for 1.5 h, washed with PBS, 
and incubated with an FITC- or TRITC-labeled secondary antibody (1:200 dilution) in PBSB for 
45 min at room temperature. Cells were washed 3 times with PBS and stained with 1:5,000 
Hoechst dye for 5 min, mounted on glass slides with Moviol, and images were captured with a 
Zeiss (Oberkochen, Germany) Observer fluorescent microscope with a 63x oil objective lens 
with a numerical aperture of 1.4 and an Axiocam Mrm camera. TIF files were exported with 
AxioVision software (Zeiss).  
 
For super-resolution microscopy, Alexa Fluor 647, and Alexa Fluor 488-labeled secondary 
antibodies (ThermoFisher) were used. After washing, coverslips were mounted to slides using 
ProLong Diamond antifade super-resolution imaging mountant (ThermoFisher). Super-resolution 
images were imaged using Leica (Wetzlar, Germany) TCS SP8 STED super-resolution 
microscope. Images were quantified using the NIH ImageJ software and assembled into figures 
with Photoshop Elements (Adobe, San Jose, CA). To clearly show the Golgi structure, brightness 
or contrast was adjusted linearly across all samples within each experiment. 
 
For calcium imaging, GRASP55-GCaMP7 transfected cells were plated onto glass bottomed 
dishes and imaged by a Nikon C2-plus Laser Scanning Confocal Microscope System configured 
with a Ti2-E inverted microscope. Images were captured at 488 nm and 561 nm in sequential 
scanning mode. Z-stacks of 5 slices at 1 µm interval were acquired every 30 seconds for a total 
period of 10 min. The NIS-Elements C software was used for acquisition, analysis and 
visualization. The "+Histamine" symbol in Movie S1 was added in Adobe Premiere Pro 2020. 
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For quantification, fluorescence intensity was measured every minute for 60 min. 20 cells were 
measured for each drug treatment. 
 
To quantify Golgi fragmentation, cells were evaluated by eye under a microscope according to 
predefined fragmentation criteria, at least 300 cells were counted in each reaction. The following 
criteria are used to define whether a Golgi is intact or fragmented: 1) If the Golgi exists as a 
single piece of connected membrane, it is intact. 2) If a Golgi exhibits several items that are 
connected by visible membrane bridges, even though these bridges might be faint, the Golgi is 
considered intact. 3) If a Golgi exhibits ≥ 3 disconnected pieces (no visible bridges connecting 
them), then the Golgi is fragmented. 4) Mitotic cells, defined by the DNA pattern, and 
overlapping cells in which the Golgi pattern is difficult to define, are not counted. Hoechst was 
used to identify individual, mitotic and overlapping cells. In experiments where transfected 
proteins were employed, only transfected cells were counted, and 100 cells were counted per 
replicate. In experiments where an inhibitor screen was performed, an unbiased image 
thresholding method was used to extract fragmentation data from ≥40 cells per replicate.  
 
Protein Biochemistry  
For immunoblotting, cells from a culture dish were pelleted and lysed with 30 µl lysis buffer (40 
mM Hepes, pH 7.4, 200 mM KCl, 5 mM MgCl2, 1% Triton X-100 (Bio-Rad, Hercules, CA), 50 
mM beta-glycerol phosphate, protease inhibitor cocktail (Roche), and phosphatase inhibitors 
NaF and NaVan pH 8.0). Samples were mixed with 6X SDS-PAGE sample buffer (400 mM 
Tris-Cl pH 6.8, 15% SDS, 10 mM DTT, 50% glycerol, 0.05% bromophenol blue), denatured at 
95°C for 4 min and then run on PAGE gels. For Fig. 2.12, subpanels C and D 8% gels were run 
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at 4°C for 8 h. Protein was transferred to nitrocellulose membranes using semi-dry transfer (Bio-
Rad, Hercules, CA) at constant 16 V. Membranes were blocked for 10 min with 3% milk in 
0.2% Tween-20 in phosphate buffered saline (PBST) and immunoblotted. Western blots were 
captured with Enhanced Chemiluminescence (ECL) dye reagent (ThermoFisher), in a 
FluorChem M chemi-luminescent imager (ProteinSimple, San Jose, CA). 
 
Electron Microscopy (EM) 
For EM, cells were fixed in pre-warmed serum-free DMEM, 20 mM Hepes, pH 7.4, 2% 
glutaraldehyde at room temperature for 30 min or 4°C overnight as previously described (Tang et 
al., 2010a). Cells were washed 2 times with 0.1 M Sodium cacodylate (Electron Microscopy 
Sciences, Hatfield, PA), and post-fixed on ice in 1% v/v reduced Osmium tetroxide, 0.1 M 
Sodium cacodylate (w/v) and 1.5% cyanoferrate (w/v) in water. Cells were rinsed 3 times with 
50 mM maleate buffer, pH 5.2, 3 times with water, scraped, and pelleted in microcentrifuge 
tubes for embedding. The EMBED 812 (EMD) protocol was used to embed cells and resin 
blocks were sectioned to 60 nm with a diamond knife and mounted on Formvar-coated copper 
grids. Samples were double contrasted with 2% uranyl acetate then with lead citrate and rinsed 
with copious amounts of water. Grids were imaged using a Philips (Amsterdam, Netherlands) 
transmission electron microscope. Golgi images were captured at 11,000x magnification. Golgi 
stacks were identified using morphological criteria and quantified using standard stereological 
techniques. A Golgi cisterna was identified as a perinuclear membrane within a Golgi stack ≥4 
times longer than its width. Stack length was measured for the longest cisterna within a Golgi 
stack using the ruler tool in Photoshop Elements 13. For the number of cisternae per stack, the 
number of cisternae was counted. For the number of vesicles per stack, round objects no greater 
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than 80 µm in diameter within 0.5 µm of a Golgi stack were counted. At least 20 cells were 
quantified in each experiment, and the EM results represent two independent experiments. 
 
VSV-G Trafficking using RUSH system 
VSV-G trafficking was performed as previously described (Li et al., 2019b). Briefly, HeLa cells 
were transfected with the Str-li_VSVG wt-SBP-EGFP plasmid (Boncompain et al., 2012) and 
cultured at 37°C for 16 h. Cells were then incubated with 250 nM TG or 10 µM monensin in 
fresh medium for 0.5 h at 37°C before 40 µM D-biotin (VWR Life Science, Radnor, PA) was 
added. Cells were then lysed at indicated time points (chase), treated with or without EndoH, and 
analyzed by Western blotting for VSV-G-GFP using a GFP antibody. The percentage of EndoH 
resistant VSV-G was quantified using the ImageJ software. 
 
Molecular Cloning  
Catalytically inactive PKCα, PKCα-GFP (K368R), was made in-house using site-directed 
mutagenesis. Constructs for GRASP55 truncation mutants, aa1-212, aa1-250, aa1-300, aa1-400, 
aa1-430 were constructed in pEGFP-N1 vector using BamHI and HindIII sites (Zhang et al., 
2018). GRASP55 phosphorylation deficient mutants, S255A, S260A, S262A/S263A, S269A, 
S273A/T274A, T278A, S289A and S292A were constructed by site-directed mutagenesis. The 
genetically encoded calcium indicator GRASP55-GCaMP7 was made in-house by inserting the 
GCaMP7a gene (kind gift from Dr. Haoxing Xu) into a pmCherry-N1-GRASP55 WT vector 
(Zhang et al., 2018) using BamH1 and NotI restriction sites. All cDNAs generated in this study 




In vitro Kinase Assay 
In the presence or absence of 2 mM ATP, twenty μg/ml recombinant GRASP55 protein (Xiang 
and Wang, 2010) was incubated with 10 μg/ml (for WB) or 20 μg/ml (for Coomassie blue 
staining) recombinant PKCα (SignalChem, British Columbia, Canada), respectively. Reactions 
were performed in kinase buffer (20 mM HEPES-NaOH, pH 7.4, 1 mM CaCl2, 1 mM DTT, 10 
mM MgCl2, 200 μg/ml phosphatidylserine, 20 μg/ml diacylglycerol) at 30°C for 3 h. Reactions 
were terminated by adding SDS sample buffer and boiling. GRASP55 proteins were separated by 
Phos-tag SDS-PAGE and visualized by Coomassie blue staining or immunoblotting. In brief, 50 
μM Phos-tag acrylamide and 100 μM MnCl2 were included in the gel recipe according to the 
manufacturer’s instructions. Phos-tag gels were washed twice in water and stained by Coomassie 
blue or three times in transfer buffer supplemented with 10 mM EDTA and twice in transfer 
buffer without EDTA before transferring to membranes. 
 
Quantitation and Statistics 
All data represent the mean ± SEM (standard error of the mean) of at least three independent 
experiments unless noted. A statistical analysis was conducted with two-tailed Student’s t-test in 
the Excel program (Microsoft, Redmond, WA). Differences in means were considered 
statistically significant at p ≤ 0.05. Significance levels are: *, p<0.05; **, p<0.01; ***, p<0.001. 
Figures were assembled with Photoshop (Adobe, San Jose, CA). Pearson's colocalization 







Fig. 2.1 TG treatment induces Golgi fragmentation and UPR 
(A) Short term TG treatment causes Golgi fragmentation. HeLa cells were treated with 250 nM 
TG, fixed at the indicated time points, and stained for GM130 (cis-Golgi) and TGN46 (trans-
Golgi). Scale bar, 20 µm. (B) Quantitation of A for cells with fragmented Golgi using GM130 as 
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the Golgi marker. (C) HeLa cells were treated with DMSO, 250 nM TG for 20 min, 5 µM Tm 
for 6 h, or 10 mM DTT for 2 h. Cells were stained for GM130 (green) and TGN46 (red) and 
analyzed by super-resolution microscopy. (D) Pearson's correlation coefficients of GM130 and 
TGN46 signals in C. Two-tailed Student's t-tests were used to calculate statistical significance 
(**, p ≤ 0.01). (E) Longer term TG treatment results in ER stress. Cells treated as in A were 
analyzed by Western blot of indicated proteins. Note that TG treatment increases the levels of p-
eIF2α, Bip and CHOP. (F-G) Quantitation of the ratio of p-eIF2α/eIF2α and the Bip levels from 
(E), with the no-treatment control normalized to 1. All quantitation results are shown as Mean ± 
SEM from at least 3 independent experiments; statistical analyses were performed using two-





Fig. 2.2 TG-induced Golgi fragmentation is reversible  
(A) TG-induced Golgi fragmentation is reversible. Cells were treated with either DMSO or 100 
nM TG for 1 h. After washing out TG, TG-treated cells were incubated in fresh growth medium 
for the indicated times and stained for GM130 (red) and DNA (blue). (B) Quantitation of A for 
cells with fragmented Golgi. For statistical analyses, treated cells were compared to the DMSO 
control (Ctrl). *, p ≤ 0.05; **, p ≤ 0.01. (C) Acute TG treatment does not cause apoptosis. Cells 
were treated with either DMSO or 100 nM TG for 20 min without or with 6 h washout, or with 2 
µM staurosporine (STS) for 4 h, and stained for GM130 and DNA. (D) Cells in C were surface 
stained with Annexin V-EGFP. Scale bars in all fluorescent images, 20 µm. (E) Cells were 
treated with 0.5 µM latrunculin B for 2 h and 250 nM TG was added for the last 20 min. Cells 
were stained for F-actin with phalloidin (red) and GM130 (green). Scale bar, 20 µm. (F) Cells 
were treated with 1 µM Noc for 2 h and 250 nM TG was added for the last 20 min. Cells were 







Fig. 2.3 Tm treatment induces UPR but not Golgi fragmentation  
(A) Tm treatment has no effect on the Golgi morphology. HeLa cells were treated with 5 µg/ml 
Tm for indicated times and stained for GM130 (green) and TGN46 (red). Scale bar, 20 µm. (B-
C) Quantitation of Golgi fragmentation in Tm-treated cells in A. (D) EM micrographs of the 
Golgi region in Tm-treated cells. Scale bar, 0.5 µm. (E) Tm-treated cells as in A were analyzed 
by Western blots. Note the increased levels of p-eIF2, Bip and CHOP over time. (F-G) 
Quantitation of p-eIF2/eIF2α and Bip in E. Results are shown as Mean ± SEM from at least 3 
independent experiments; statistical analyses were performed using two-tailed Student's t-tests 
(*, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001). (H) Representative EM images of ER cisternae in 
cells treated with DMSO (Ctrl) or tunicamycin (Tm, 5 µg/ml) for 6 h. ER cisternae in Ctrl cells, 
indicated by arrowheads (►), appear to have a narrow, intact structure; where in Tm treated 
cells, the ER cisternae appear to be swollen and fragmented, as indicated by arrows (→). Scale 





Fig. 2.4 DTT treatment induces UPR but not Golgi fragmentation 
(A) HeLa cells were treated with DMSO or 10 mM DTT for indicated times and stained for 
GM130 (green), and TGN46 (red). Scale bar, 20 µm. (B) Quantitation of A for cells with 
fragmented Golgi. (C) Western blots of ER stress and Golgi proteins showing UPR induction 
upon DTT treatment. (D) Quantitation of Bip levels from four independent experiments. Two-





Fig. 2.5 TG induces Golgi fragmentation prior to UPR through elevated cytosolic Ca2+ 
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(A) HeLa cells were treated with the indicated concentrations of TG for 20 min and stained for 
GM130. Scale bar, 20 µm. (B) Quantitation of cells with fragmented Golgi in A. (C) Cells 
treated with TG as in A were analyzed by Western blots. (D-E) Quantitation of p-eIF2α/eIF2α 
and Bip in C from five independent experiments. (F) BAPTA-AM inhibits TG-induced Golgi 
fragmentation. HeLa cells treated with 100 nM TG for indicated times with or without 60 µM 
BAPTA-AM (B/AM) 30 minute pre-treatment, and stained for GM130. Scale bar, 20 µm. (G) 
Quantitation of F from three independent experiments. (H) Electron micrographs of Golgi 
profiles in HeLa cells treated with 250 nM TG and B/AM for 20 min. Note that the Golgi is 
comprised of bulbous saccules in the TG-treatment, whereas in the B/AM pretreated cells the 
cisternae appear straight and well-stacked. Asterisks (*) indicate nuclei. Scale bar, 0.5 µm. (I) 
Quantitation of the morphological features of Golgi stacks on the EM images in H. For statistics, 






Fig. 2.6 BAPTA-AM inhibits TG-induced Golgi fragmentation  
(A) HeLa cells were pretreated with BAPTA-AM for 10 minutes in the amounts shown and then 
treated with 250 nM TG for 20 minutes, and then with 250 nM TG for 20 min followed by 
immunostaining of GM130 and TGN46. Scale bar, 20 µm. (B) Quantitation of cells in (A) with 
fragmented Golgi based on the GM130 pattern in the cell. Quantitation of %cells w. Golgi frag. 
in B from 3 independent experiments. Two-tailed Student's t-tests were used to calculate 





Fig. 2.7 Low concentration of TG induces Golgi fragmentation in NRK cells and RAW 
264.7 macrophages 
(A) NRK cells were treated with the indicated concentrations of TG for 20 min and stained for 
GM130. Scale bar, 20 µm. (B) Quantitation of cells with fragmented Golgi in A. (C) Cells 
treated with TG as in A were analyzed by Western blots. (D-E) Quantitation of p-eIF2α/eIF2α 
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and Bip in C from 3 independent experiments. (F) RAW 264.7 murine macrophage cells were 
treated with the indicated concentrations of TG for 20 min and stained for GM130. Scale bar, 10 
µm. (G) Quantitation of cells with fragmented Golgi in F. (H) Cells treated with TG as in F were 
analyzed by Western blots. (I-J) Quantitation of p-eIF2α/eIF2α and Bip in H from 3 independent 
experiments. Two-tailed Student's t-tests were used to calculate statistical significance (*, p ≤ 





Fig. 2.8 TG-induced Golgi fragmentation increases protein trafficking in the Golgi 
69 
 
(A) Cells were transfected with the Str-li_VSVG wt-SBP-EGFP plasmid for 16 h followed by a 
30 min treatment with DMSO, 250 nM TG, or 10 µM monensin (Mo) at 37°C. Cells were then 
incubated with complete medium containing 40 µM biotin (chase) for the indicated times, lysed 
and treated with (+) or without (-) EndoH, and analyzed by Western blot for GFP. (B) 
Quantification of A for the percentage of EndoH resistant VSV-G from three independent 
experiments. Quantitation results are shown as Mean ± SEM. Statistical analyses were performed 
using two-tailed Student's t-tests by comparing to the control (*, p ≤ 0.05). (C) Representative 
images of A showing the subcellular localization of VSVG-EGFP at indicated time points after 
biotin chase. Scale bar, 20 µm. (D) Fluorescent images showing the subcellular localization of 
ManII-GFP in cells treated with DMSO (Ctrl) or 250 nM TG at the indicated time points of BFA 
washout. ManII-GFP appears in the Golgi area beginning at 60 min, whereas this takes longer in 





Fig. 2.9 TG induces Golgi fragmentation through PKCα activation 
(A) Inhibition of PKC reduces TG-induced Golgi fragmentation. HeLa cells were pre-treated 
with DMSO, BAPTA-AM (B/AM, 60 µM for 10 min), staurosporine (STS, general kinase 
inhibitor, 2 µM for 10 min), KN-62 or KN-93 (CAMKII inhibitors, 10 µM and 5 µM, 
respectively, 10 min), or BIM1 or Gӧ6976 (PKC inhibitors, 2 µM and 4 µM, respectively, 10 
min), and then with 250 nM TG for 20 min followed by immunostaining of GM130 and TGN46. 
Scale bar, 20 µm. (B) Quantitation of cells in (A) with fragmented Golgi based on the GM130 
pattern in the cell. (C) HeLa cells were treated with 100 nM PMA for 1 h; 4-alpha-PMA of the 
same concentration was used as a control. (D) Quantitation of cells with fragmented Golgi in C. 
(E) Cells treated as in C were analyzed by Western blot to show that PMA treatment does not 





Fig. 2.10 PKCα localizes to the Golgi upon activation  
(A) Expression of PKC isoforms. HeLa cells were transfected with indicated PKC isoforms and 
analyzed by Western blot for GFP or PKCα. (B) Fluorescent images showing the localization of 
expressed PKC isoforms after treatment with DMSO, 4-alpha, or PMA. PMA induces PKCα (α-
GFP) localization to the Golgi area, a similar but less dramatic effect was observed for PKCβII 





Fig. 2.11 PKCα is required for Golgi fragmentation during PKCα activation  
(A) Activation of ectopically expressed PKCα triggers its Golgi localization (indicated by “→”) 
and Golgi fragmentation (*). Cells transfected with GFP or PKCα-GFP were treated with 100 
nM PMA or 4-alpha for 1 h. Note the fragmented Golgi in these cells upon PMA treatment. 
Scale bar, 20 µm. (B) Quantitation of cells in A with fragmented Golgi. (C) Western blot of cells 
from A showing that ectopic PKC expression does not alter the endogenous PKCα expression 
level. (D) PKCα-GFP (K368R) expressed in HeLa cells and treated with either 4-alpha or PMA 
and visualized by Western blotting. (E) Cells in D were probed for GM130 (red) and DNA 
(blue). (F) HeLa cells were transfected with control (Ctrl-i) or PKC-specific siRNA for 48 h and 
then treated with 250 nM TG for 20 min. Cells were fixed and stained for GM130 (green) to 
show the Golgi structure. Scale bar, 20 µm. (G) Quantitation of Golgi fragmentation of cells in 
F. (H) Cells in F were blotted for endogenous PKCα to evaluate the siRNA knockdown 
efficiency. All quantitation results are shown as Mean ± SEM from three independent 
experiments. Statistical analyses were performed using two-tailed Student's t-tests (*, p ≤ 0.05; 





Fig. 2.12 PKCα induces Golgi fragmentation through GRASP55 phosphorylation 
(A) TG treatment results in the phosphorylation of GRASP55 but not other Golgi proteins. HeLa 
cells were treated with 250 nM TG for 1 h, with or without 2 µM staurosporine (STS) pre-
treatment for 10 min, and analyzed by Western blot. (B) Cell lysates in A were analyzed by 
phos-tag gels and Western blot. (C) GRASP55 is phosphorylated upon TG treatment. HeLa cells 
treated with Tm, TG or nocodazole (Noc) were analyzed by phos-tag gels and Western blot. 
Note the mobility shift of GRASP55 upon TG treatment compared to control (Ctrl). Nocodazole-
arrested mitotic cells were used as a positive control for GRASP55 phosphorylation. (D) 
Quantitation of GRASP55 phosphorylation in TG treated cells. The intensity of the 
phosphorylated (upper) band was quantified by densitometry analysis, and plotted relative to the 
intensities of the full length (lower) band. Shown are the results of relative phosphorylation of 
GRASP55 from 3 independent experiments. (E) PKCα phosphorylates GRASP55 in vitro. 
Phosphorylated GRASP55 (►) was analyzed by phos-tag gels and visualized using Coomassie 
blue staining. (F) PKCα phosphorylates GRASP55 in vitro. Purified PKCα and GRASP55 were 
incubated in a kinase buffer with or without ATP as indicated, and analyzed by phos-tag gels and 




Fig. 2.13 Phosphorylation of GRASP55 within aa251-300 is important for TG-induced 
Golgi fragmentation 
(A) Mapping the phosphorylation site on GRASP55 by expressing GRASP55 truncation 
mutants. Indicated GFP-tagged GRASP55 constructs were expressed in HeLa cells. After TG 
treatment, GRASP55 was analyzed by mobility shift. Note the mobility shift in lanes 8, 10, and 
12. (B) Quantitation of GRASP55 phosphorylation in TG treated cells from A. (C) TG-induced 
Golgi fragmentation is rescued by the expression of non-phosphorylatable GRASP55 proteins. 
Cells expressing the indicated GRASP55 constructs were stained for giantin. (D) Quantitation of 
cells in C with fragmented Golgi. Results are shown as Mean ± SEM. Statistical analyses were 





Fig. 2.14 Histamine treatment alters the Golgi structure 
HeLa cells treated with either DMSO (control, 1 h) or histamine (100 µM, 1 h) were analyzed by 
EM. Shown are collections of electron micrographs representing the two treatments. Consistent 
aberrations in Golgi shape were frequently seen in histamine-treated cells, including reduced 





Fig. 2.15 Histamine induces Golgi fragmentation through PKC activation 
(A) HeLa cells were treated with indicated concentrations of histamine for 1 h, stained for 
GM130, and quantified for the percentage of cells with fragmented Golgi. Shown are the 
quantitation results. (B) HeLa cells were treated with 100 µM histamine for the indicated times 
and analyzed as in A. Note that histamine induced Golgi fragmentation within 2 h. (C) Electron 
micrographs of Golgi profiles in HeLa cells treated with DMSO control (Ctrl, left panel) or 100 
µM histamine for 1 h (right panel). Note the reduced size of the Golgi in histamine-treated cells. 
Scale bar, 0.5 µm. (G) Expression of the GRASP55-GCaMP7 Golgi Ca2+ sensor. HeLa cells 
transfected with indicated proteins were analyzed by Western blot for GFP. (H) Histamine 
treatment increases the GRASP55-GCaMP7 signal. HeLa cells were co-transfected with 
mCherry-GM130 (red) and GRASP55-GCAMP7 (green). Shown are still frames before (left 
panel) or after (right) histamine was added. (I) TG and ionomycin treatments increase the 
GRASP55-GCaMP7 signal. HeLa cells expressing GRASP55-GCaMP7 were treated with 100 
µM histamine (Hist), 250 nM TG, or 1 µM ionomycin (Io) for 1 h. Shown are the quantitation of 
the fluorescence intensity before and after the drug was added. All quantitation results are shown 
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as Mean ± SEM. Statistical analyses were performed using two-tailed Student's t-tests (*, p ≤ 





Fig. 2.16 Proposed model of PKCα during stress 
Under normal conditions (upper left), cells contain intact Golgi and low cytosolic calcium. 
Under certain types of calcium stress, such as during histamine or thapsigargin treatment, the 
Golgi becomes fragmented and unstacked (upper right). This morphology is accompanied by an 
increase in cytosolic calcium and activation of PKCα which localizes to the Golgi membrane and 














Hydrogen Peroxide Induces Arl1 Degradation and Impairs Golgi-Mediated Trafficking3 
 
3.1 Abstract 
Reactive oxygen species (ROS)-induced oxidative stress has been associated with diseases such 
as amyotrophic lateral sclerosis (ALS), stroke and cancer. While the effect of ROS on 
mitochondria and endoplasmic reticulum (ER) has been well documented, its consequence on the 
Golgi apparatus is less well understood. In this study, we characterized the Golgi structure and 
function in HeLa cells after exposure to hydrogen peroxide (H2O2), a reagent commonly used to 
introduce ROS to cells. Treatment of cells with H2O2 resulted in the degradation of Arl1 and 
dissociation of GRIP-domain containing proteins Golgin-97 and Golgin-245 from the trans-
Golgi. This effect could be rescued by treatment of cells with protease inhibitors. Structurally, 
H2O2 treatment reduced the number of cisternal membranes per Golgi stack, suggesting a loss of 




3 This chapter is modified from a version that has been submitted to the journal Molecular 
Biology of the Cell with authors listed as Stephen C. Ireland, Haoran Huang and Yanzhuang 




protein transport, consistent with the loss of membrane tethers on the trans-Golgi cisternae. This 
study revealed membrane tethers at the trans-Golgi as novel specific targets of ROS in cells. 
 
3.2 Introduction 
In eukaryotic cells the reduction of O2 to H2O during ATP generation in the mitochondria 
necessarily leads to the production of reactive oxygen species (ROS). ROS can damage various 
cellular components such as lipids, proteins and nucleic acids. Oxidative stress of cells occurs 
when damage to cellular components is high enough to lead to a constellation of system failures. 
For example, treatment of hemoglobin and rat globular basement membrane with hydrogen 
peroxide (H2O2) makes them more susceptible to proteolytic cleavage (Davies, 2016; Fligiel et 
al., 1984). In addition, oxygen free radicals such as superoxide anion, singlet oxygen, hydroxyl, 
and perhydroxyl, either generated by the cell or from an external source, can cause the death of 
multiple cell types in vitro and are thought to contribute to many inflammatory conditions 
(Ahsan et al., 2003; Singh et al., 2007). High levels of oxidative stress are often associated with 
diseases such as cancer, diabetes, atherosclerosis, stroke, and neurodegenerative disorders such 
as amyotrophic lateral sclerosis (ALS), in which there is a failure in the cells to reduce ROS 
(Manoharan et al., 2016; Nindl et al., 2004). 
 
ROS can damage membrane organelles. For example, oxidation and thereby inactivation of 
protein tyrosine phosphatases (PTPs) can increase steady-state protein phosphorylation of eIF2α 
and endoplasmic reticulum (ER) stress through redox inhibition of protein phosphatase 1 (Santos 
et al., 2016). H2O2 treatment inactivates catalase and disrupts mitochondria in Hs27 human 
fibroblasts, and increases the secretion of matrix metalloproteases (Koepke et al., 2008). H2O2 
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can also damage the fluidity and function of the plasma membrane in vascular endothelial cells 
(Block, 1991). So far, how ROS affects the structure and function of the Golgi apparatus has not 
been well documented. 
 
The Golgi is a membrane organelle with a stacked structure that functions as a trafficking hub in 
the cell for the delivery of proteins and lipids to their final destinations. In anterograde 
trafficking, the cis Golgi cisternae receive proteins synthesized by the ER in COPII vesicles and 
sends them to the endosomal/lysosomal system, the plasma membrane, or outside of the cell. In 
retrograde trafficking, the trans face of the Golgi receives vesicles from the plasma membrane 
and endosomes for subsequent delivery to the ER (Huang and Wang, 2017). These functions rely 
on a group of long coiled-coil proteins called golgins, which act as membrane tethers to capture 
vesicles and facilitate their fusion with the Golgi membranes (Lupashin and Sztul, 2005; 
Muschalik and Munro, 2018; Witkos and Lowe, 2015; Xiang and Wang, 2011). These include 
GM130 in the cis-Golgi that functions in ER-to-Golgi trafficking, and a group of four GRIP 
(“Golgin-97, ranBP2alpha, imh1p and p230/golgin-245”)-domain containing proteins, Golgin-
97, Golgin-245, GCC88 and GCC185, in the trans-Golgi (Jackson, 2003; Lu and Hong, 2003; 
Luke et al., 2003).  
 
The GRIP-domain containing golgins are important for both anterograde and retrograde 
trafficking at the trans-Golgi (Munro, 2011). GCC88 and GCC185 have been shown to differ in 
their membrane binding properties and localize to distinct subdomains of the trans-Golgi, and 
facilitate the sorting and delivery of distinct cargo sets to and from the trans-Golgi network 
(TGN) (Derby et al., 2004). Golgin-97 and Golgin-245 localize to overlapping but non-identical 
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subdomains of the TGN and mediate endosome-to-Golgi trafficking (Lu et al., 2004; Wong and 
Munro, 2014), but only Golgin-97 has been implicated in the anterograde trafficking of E-
Cadherin to the cell surface (Lock et al., 2005). Therefore, the GRIP domain tethers regulate the 
transport of diverse cargo molecules. The GRIP domain of Golgin-97 and Golgin-245 anchors 
these golgins to the trans-Golgi by the interaction with Arl1 (ADP-ribosylation factor-like 
protein 1), a member of the ARF/Arl family of small GTPases that is localized on trans-Golgi 
membranes. Depletion of Arl1 by RNAi causes dissociation of Golgin-97 and Golgin-245 from 
the trans-Golgi membranes and impairs both anterograde and retrograde trafficking at the TGN 
(Nishimoto-Morita et al., 2009).  
 
In this study we determined the effect of ROS on Golgi structure and function by acute treatment 
of cells with H2O2. We found that H2O2 treatment resulted in a reduction of the number of Golgi 
cisternae in the stacks, a rapid loss of Arl1, and dissociation of Golgin-97 and Golgin-245 from 
the trans-Golgi, which impaired both anterograde and retrograde trafficking. This study revealed 
the trans-Golgi and trafficking at the trans-Golgi as novel targets of ROS in cells, which may 
help understand the toxicity of ROS in human diseases. 
 
3.3 Results 
3.3.1 H2O2 treatment causes specific degradation of Arl1 and its binding partners Golgin-97 
and Golgin-245 
Oxidative stress is most frequently studied using hydrogen peroxide (H2O2), a membrane-
permeable source of the peroxide ion (O2
2-) that is relatively stable in aqueous solutions (Stone 
and Yang, 2006). To investigate the effect of ROS on the Golgi, we applied H2O2 to HeLa cells 
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in culture for 10 min with increasing concentrations consistent with physiological levels present 
in cells (Schroder and Eaton, 2008). Since it has been previously shown that ROS triggers 
protein degradation (Pajares et al., 2015), we first examined the effect of H2O2 treatment on the 
level of Golgi structural proteins by Western blotting. As shown in Fig. 3.1A, H2O2 treatment at 
1.4 mM, the highest concentration we tested, had no significant effects on most Golgi structural 
proteins, including GCC88, GCC185, GM130, GRASP65, GRASP55, Golgin-160, cation 
independent mannose-6-phosphate receptor (CI-M6PR), and syntaxin 6. However, Arl1, Golgin-
97 and Golgin-245 were significantly reduced. In this experiment we also tested α-tubulin, a 
microtubule protein that has previously been shown to be degraded upon 200 µM H2O2 treatment 
for 1 or 4 h (Hu and Lu, 2014). However, total α-tubulin level was unaffected in our 
experiments, possibly because we used a shorter time for the treatment, indicating that our 
experimental condition is milder than that of previous studies. Syntaxin 6 is an important 
SNARE protein in TGN trafficking (Bock et al., 1997), but the level of syntaxin 6 remained 
unchanged after H2O2 treatment at all concentrations. Based on these results, we chose to use 1 
mM H2O2 and 10 min for the treatment in most of our following experiments; at this condition 
Arl1, Golgin-97 and Golgin-245 are degraded whereas GM130 and other Golgi structural 
proteins did not change. 
 
As an alternative approach, we performed high-speed centrifugation to separate cytosolic 
proteins from cellular membranes. This approach allowed us to examine not only the protein 
level, but also the membrane association of Arl1 and other proteins (Fig. 3.1B). As controls we 
used GS28 and actin as markers for membranes and cytosol, respectively. As shown in Fig. 
3.1B, Arl1, Golgin-97 Golgin-245, GCC88, and GCC185 were all enriched in the membrane 
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fraction of control cells. After H2O2 treatment, Arl1, Golgin-97 and Golgin-245 were reduced in 
the membrane fractions, while GCC88 was relatively stable, consistent with the results shown 
above. 
 
3.3.2 H2O2 treatment reduces membrane association of GRIP domain-containing golgins in 
trans-Golgi 
Our results showed that H2O2 treatment reduced the protein level of Arl1, Golgin-97 and Golgin-
245 but not the other two GRIP domain-containing golgins, GCC88 and GCC185 (Fig. 3.1). To 
further confirm that H2O2 treatment reduces the level of GRIP domain-containing golgins in the 
Golgi by an alternative method, we analyzed their subcellular localization by 
immunofluorescence microscopy. As shown in Fig. 3.2A-B, H2O2 treatment reduced the level of 
Arl1 and Golgin-97 in the Golgi region indicated by GM130 in a dose dependent manner. 
Similarly, Golgin-245 also reduced its level in the Golgi region (Fig. 3.3). Unlike Golgin-97 and 
Golgin-245, GCC88 and GCC185 signals reduced in the Golgi region but increased in the 
cytosol after H2O2 treatment (Fig. 3.3), indicating that GCC88 and GCC185 were dissociated 
from the Golgi, although they were not degraded (Figure 3.1A). Taken together, our results 
indicate that H2O2 treatment reduces the level of membrane tethers in the trans-Golgi 
membranes. 
 
3.3.3 Short term H2O2 treatment does not cause Golgi fragmentation but reduces the 
number of cisternae per Golgi stack 
Because no significant change was observed in the Golgi morphology by immunofluorescence 
microscopy using GM130 and TGN46 as markers (Fig. 3.4A-B), we next performed electron 
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microscopy (EM) to analyze the ultrastructure of the Golgi stacks in more detail. As shown in 
Fig. 3.5, the average number of Golgi cisternae per stack was reduced by H2O2 treatment (3.5 ± 
0.3) compared to that of control cells (4.8 ± 0.3), indicating a loss of Golgi cisternae. Previously, 
we have observed that depletion of GRASP65 and/or GRASP55 reduces the number of cisternae 
in the Golgi stack and the length of the Golgi cisternae, resulting in vesiculation of Golgi 
membranes (Bekier et al., 2017; Xiang and Wang, 2010). However, unlike GRASP depletion, 
the number of vesicles surrounding each Golgi stack did not significantly change after H2O2 
treatment, nor did the average length of the stacks (Fig. 3.5; Fig. 3.6). The shape of the Golgi 
cisternae appeared to be normal, with flat, well aligned cisternae within the stacks, and with 
narrow and uniform gaps between them. The reduction in cisterna number in the stacks and the 
loss of trans-Golgi membrane tethers suggest a possibility that trans-Golgi cisternae were 
removed or reduced after H2O2 treatment. 
 
3.3.4 H2O2 treatment reduces anterograde and retrograde trafficking 
Arl1 and the GRIP domain-containing golgins are best known for their roles in tethering vesicles 
from the endosomes to facilitate their fusion with Golgi membranes. To determine the effect of 
H2O2 treatment on retrograde trafficking, we first looked at the subcellular localization of CI-
M6PR, which is constantly recycled between the TGN and late endosomes. While treatment of 
cells with 1 mM H2O2 had no effect on the protein level of CI-M6PR at various time points (Fig. 
3.7A), the CI-M6PR signal in the Golgi region reduced over time (Fig. 3.7B-C). The reduction 
of the CI-M6PR signal in the Golgi region indicates an inhibition of CI-M6PR trafficking from 
the endosomes to the Golgi in H2O2-treated cells. As a complimentary approach, we used Shiga 
toxin 1 B subunit (StxB) as a tool to measure retrograde trafficking (Selyunin and 
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Mukhopadhyay, 2015a). Cells were first incubated with StxB at 4ºC to allow it to bind to the cell 
surface, and then warmed up to 37ºC to allow StxB trafficking toward the Golgi (chase). After 
60 min chase, StxB was accumulated in the Golgi region in control cells; in contrast, it existed 
mostly as cytoplasmic puncta in H2O2-treated cells (Fig. 3.7D). Consistent with the loss of Arl1 
tethering complexes, our results demonstrate that H2O2-treatment impairs the function of the 
trans-Golgi in retrograde trafficking.  
 
Since TGN also play essential roles in anterograde trafficking, we determined the effect of H2O2 
treatment on Vesicular Stomatitis Virus-Glycoprotein (VSV-G) trafficking using the RUSH 
system (Boncompain et al., 2012). Cells were transfected with a plasmid that encodes both the 
invariant chain of the major histocompatibility complex (Ii, an ER protein) fused to core 
streptavidin and VSV-G fused to streptavidin-binding peptide (SBP). Under normal conditions 
the interaction between streptavidin and SBP retains VSV-G in the ER. Upon the addition of 
biotin, this interaction is displaced by the strong binding of biotin with SBP, resulting in the 
release of the VSV-G reporter from the ER for trafficking to the plasma membrane. Since VSV-
G is a glycoprotein, we used endoglycosidase H (EndoH) to distinguish its core (ER and cis-
Golgi) and complex (post-Golgi) glycosylation forms as an indicator of trafficking. As shown in 
Fig. 3.7F, H2O2 treatment decreased the EndoH resistant post-Golgi forms of VSV-G at 30 and 
60 min time points after release compared to that in the control, demonstrating that H2O2 
treatment decreased VSV-G trafficking through the Golgi. Using the same experimental scheme, 
we also labelled cell surface VSV-G with an antibody that recognizes its extracellular domain in 
unpermeabilized cells at different time points to determine its arrival to the plasma membrane 
after release. In the control treatment, VSV-G started to appear at the cell surface after 30 min 
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release; whereas in H2O2 treated cells VSV-G was still undetectable after 60 min release (Fig. 
3.7G). Taken together, degradation of membrane tethers in the trans-Golgi upon H2O2 treatment 
impairs both anterograde and retrograde trafficking.  
 
3.3.5 H2O2 treatment causes golgin-97 degradation by cytoplasmic proteases 
As demonstrated above, Arl1, Golgin-97 and Golgin-245 are degraded upon H2O2 treatment; 
therefore, we determined whether this degradation was mediated by proteasomes or lysosomes, 
two major protein degradation pathways in the cell. Because it has been previously shown that 
oxidative stress triggers autophagy, a cellular process that delivers cargo molecules to lysosomes 
for degradation, we first inhibited autophagy and lysosomal degradation with Bafilomycin A1 
(BafA1) and determined the effect on H2O2-induced Golgi protein degradation. As shown in Fig. 
3.8A, BafA1 treatment resulted in the accumulation of p62, a cargo protein for autophagosomal 
degradation (lane 2 vs. 1), but had no effect on H2O2-induced Arl1 or Golgin-97 degradation 
(Fig. 3.8A, lane 4 vs. 3), indicating that H2O2-induced Arl1 or Golgin-97 degradation is not 
through autophagy or lysosomes. We also confirmed that the addition of BafA1 had no effect on 
H2O2-induced Golgin-97 reduction in the Golgi region by immunofluorescence microscopy (Fig. 
3.8C).  
 
Proteasomal degradation is a process in which cells target ubiquitinated proteins for degradation 
by the proteasome (Eisenberg-Lerner et al., 2020). By examining our Western blots, we did not 
detect ubiquitinated forms of Arl1 and Golgin-97. In addition, inhibition of proteasomal 
degradation by MG132 had no effect on H2O2-induced Arl1 and Golgin-97 degradation as 
examined by Western blotting or fluorescence microscopy (Fig. 3.8D-F). These results 
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demonstrated that ROS-induced Arl1 and Golgin-97 degradation is not via lysosomes or 
proteasomes. 
 
In addition to proteasomal and lysosomal degradation pathways, cytosolic proteases are known 
to degrade Golgi proteins such as Golgin-160 (Mancini et al., 2000). Therefore, we added a 
protease inhibitor cocktail (Roche) into the treatment to determine if it could rescue H2O2-
induced Arl1 degradation. This cocktail contains a set of chemicals that can effectively inhibit a 
broad spectrum of serine and cysteine proteases. As shown in Fig. 3.8G-H, the addition of the 
protease inhibitors blocked H2O2-induced Arl1 and Golgin-97 degradation. Furthermore, 
immunofluorescence microscopy confirmed that adding protease inhibitors effectively inhibited 
H2O2-induced Golgin-97 reduction in the Golgi region (Fig. 3.8I). Taken together, these results 




In this study, we revealed that H2O2 treatment induces a rapid degradation of Golgi tethering 
proteins on the trans-Golgi, including Arl1, Golgin-97 and Golgin-245, which could be rescued 
by protease inhibitors, indicating that H2O2-induced ROS activates a cytoplasmic protease to 
selectively degrade Arl1, Golgin-97 and Golgin-245 on the trans-Golgi. This results in a 
reduction of the cisternal number per Golgi stack and impairs both anterograde and retrograde 
trafficking. Our results revealed a novel mechanism by which oxidative stress within 
physiological levels induces rapid and selective degradation of Arl1 and its associated golgins on 
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the trans-Golgi, which impairs both anterograde and retrograde trafficking. This study has 
identified the Golgi as a novel site of ROS to exert its toxicity in cells.  
 
It is interesting to see that the degradation of Arl1 and its associated golgins is not by 
proteasomes or lysosomes, but rather by cytoplasmic proteases. How proteins in the Golgi are 
degraded is so far not well understood. Theoretically, Golgi proteins can be degraded by the 
following pathways: 1) by lysosome-mediated protein degradation, which requires delivery of 
Golgi proteins to the lysosomes either by direct trafficking or by autophagy; 2) by ER-associated 
degradation (ERAD), in which particular Golgi proteins traffic back to the ER for degradation by 
proteasomes; 3) by direct ubiquitination at the Golgi and degradation by the proteasomes on site; 
and 4) by cytoplasmic proteases. We originally speculated lysosomal degradation as the most 
likely mechanism for Arl1 degradation as it has previously been shown that oxidative stress 
triggers autophagy (Zhang et al., 2016) and that there is a link between Golgi function and 
autophagy (Zhang et al., 2019; Zhang et al., 2018). However, this possibility was ruled out by 
BafA1 treatment, which inhibits lysosomal degradation. Similarly, inhibition of proteasomes by 
MG132 also had no effect on Arl1 degradation. It is possible that a cytoplasmic protease may be 
more readily accessible than proteasomes or lysosomes for Arl1, Golgin-97 and Golgin-245.  
 
The identity of this cytoplasmic protease is as yet unknown and remains a subject for future 
investigation. One possible candidate is calpain, which is non-lysosomal and is known to be 
activated by ROS in intermittent hypoxia (Bailey et al., 2015). Calpain has two isoforms that are 
both calcium-activated neutral protease that function in the cytoplasm (Croall and DeMartino, 
1991). Convincing evidence for a role of these proteases is lacking for most of the described 
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functions, however calpain may proteolytically regulate PKC suggesting a possible explanation 
for why the Golgi is not fragmented during H2O2 treatment in Fig. 3.4. Calpain cleavage 
specificity is likely mediated by substrate tertiary structure and not primary protein sequence, 
which increases the difficulty to predict the precise cleavage sites on its target proteins. 
 
In contrast to some other Golgi stresses such as thapsigargin treatment that triggers Golgi 
fragmentation (Ireland et al., 2019), H2O2 does not cause obvious Golgi fragmentation, nor 
apoptosis. The loss of Arl1 and its associated golgins, together with the lack of Golgi 
fragmentation and the impairment of anterograde and retrograde trafficking in H2O2 treated cells, 
indicates that Arl1 and its associated golgins play critical roles in membrane trafficking, but may 
not be essential for Golgi structure formation. Alternatively, Golgi fragmentation may take 
longer than 10 min at which our assays were performed. Indeed, H2O2 treatment reduced the 
number of cisternae in the Golgi stack and Golgi-mediated trafficking, indicating that trafficking 
defects occur prior to Golgi fragmentation. The identity of the lost cisternae remains unknown; 
but given that Arl1 and its associated golgins reside in the trans-Golgi, it is more likely that some 
trans cisternae are lost upon H2O2 treatment, which requires further investigation. 
 
Our study revealed that the trans-Golgi is uniquely sensitive to oxidative stress in cells, which 
may help understand the toxicity of ROS in human diseases. ROS has been found to occur in 
several human diseases such as ALS, cancer and diabetes (Manoharan et al., 2016; Nindl et al., 
2004), and Golgi structural and functional defects have been observed in Parkinson’s (Mizuno et 
al., 2001), Huntington’s (Hilditch-Maguire et al., 2000) and Alzheimer’s (Joshi et al., 2015; Joshi 
et al., 2014; Joshi and Wang, 2015) diseases and ALS (Fujita and Okamoto, 2005; Gonatas et al., 
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1998; Mourelatos et al., 1996). It would be interesting to test whether Arl1 and its associated 
golgins are degraded in these diseases in future studies.  
 
3.5 Materials and Methods 
Reagents and Plasmids 
All reagents used in this study were purchased from Sigma-Aldrich (St. Louis, MO), Roche 
(Basel, Switzerland), EMD Millipore (Burlington, MA), or ThermoFisher (Waltham, MA), 
unless otherwise stated. H2O2 (30% in water) was from Fisher Chemical. Trypan blue was from 
Gibco (Dublin, Ireland). N-acetyl cysteine (NAC) was from Sigma. The cOmplete, EDTA-free 
protease inhibitor (PI) tablets were from Roche. Shiga toxin 1 Subunit B (StxB) was from BEI 
Resources (Manassas, VA). D-Biotin was from VWR Life Science (Radnor, PA). Bafilomycin 
A1 (BafA1) was from Fisher Scientific. MG132 was from EMD Millipore. The Str-li_VSVGwt-
SBP-EGFP plasmid was provided by Dr. Franck Perez (Institut Curie). 
 
Antibodies 
The following primary antibodies were used. Monoclonal antibodies against β-actin and GFP 
(Sigma-Aldrich); Shiga Toxin B (Fisher); GM130, Gos28, Golgin-245 and syntaxin 6 (BD 
Biosciences, Franklin Lanes, NJ); -tubulin (Developmental Studies Hybridoma Bank, 
University of Iowa); Arl1 (Abcam); VSV-G extracellular domain (David Sheff). Polyclonal 
antibodies against GCC88, Golgin-160, CI-M6PR, GRASP55 and GRASP65 (Proteintech); 
GCC185 (Abcam); GM130 ("N73" from J. Seemann); TGN46 (Bio-Rad). Secondary antibodies 
were purchased from Jackson Laboratory (Bar Harbor, ME). Secondary antibodies used for 
fluorescence microscopy include fluorescence-labelled goat anti-mouse, goat anti-rabbit and goat 
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anti-sheep antibodies. Secondary antibodies used for Western blot include HRP-conjugated goat 
anti-mouse and goat anti-rabbit antibodies.  
 
Cell Culture and Drug Treatments  
HeLa were obtained from ATCC (Manassas, VA), cultured in Dulbecco's modified Eagle’s 
medium (DMEM; ThermoFisher) supplemented with 10% fetal bovine serum (FBS; Gemini 
Bio-Products, Sacramento, CA) and 100 units/ml penicillin-streptomycin at 37°C with 5% CO2, 
and routinely screened for mycoplasma contamination. Cells were grown on glass coverslips 
according to standard tissue culture methods (Tang et al., 2011). Coverslips were pre-coated with 
poly-lysine (Gibco) to aid in cell attachment. H2O2, NAC and PI solutions were made fresh in 
Milli-Q water. All other drugs were dissolved in DMSO and stock solution aliquoted and stored 
at -20°C until use. Stock solutions were diluted into working solutions of DMEM or water at the 
time of the experiment. Depending on the chemical, H2O or DMSO was used as control in the 
experiments. 
 
Protein Biochemistry  
For immunoblotting, cells from a 6 cm dish were washed 3 times with ice cold PBS and 
collected with a cell scraper. Cells were pelleted and lysed with 100 µl lysis buffer (20 mM Tris-
HCl, 150 mM NaCl, 1% Triton X-100 (Bio-Rad, Hercules, CA), 20 mM glycerolphosphate and 
protease inhibitor cocktail). Samples, excluding GCC185 samples (see below), were mixed with 
6X SDS PAGE buffer with fresh DTT, denatured at 95°C for 4 min and then analyzed by SDS-
PAGE. Protein was transferred to nitrocellulose membranes using semi-dry transfer at a constant 
16 V. Membranes were blocked for 10 min with 3% milk in 0.2% Tween-20 in phosphate 
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buffered saline (PBST) and immunoblotted. GCC185 and Golgin-245 samples were denatured at 
50°C for 5 min before loading onto a SDS-PAGE and transferred to nitrocellulose membranes by 
a wet-transfer at 50 V for 2 h. Western blots were captured with enhanced chemiluminescence 




Fractionation of membranes was performed as described (Xiang et al., 2013). Briefly, control 
(Ctrl) HeLa cells and cells treated with 1 mM H2O2 for 10 min (H2O2) were washed with PBS, 
collected in HBS buffer (0.25 M sucrose, 10 mM HEPES, pH7.2, 1 mM Mg(OAc)2, 1 mM 
EDTA, 0.5 mM PMSF, and protease inhibitor cocktail) with a cell scraper, and homogenized 
using 349 a ball-bearing (Ø=8.008) homogenizer (HGM Lab Equipment) to ~80% cell breakage 
(Tang et al., 2011; Tang et al., 2010a). Plasma membrane disruption efficiency was examined by 
a trypan blue exclusion method. Homogenate was centrifuged at low speed for 10 min at 1000 g 
at 4°C. Post-nuclear supernatant (PNS) was then subjected to ultracentrifugation for 1 h in a 
TLA55 rotor at 100,000 g at 4°C to separate membranes (M) from cytosol (C). An equal amount 
of PNS, C and M were loaded onto SDS-PAGE and analyzed by Western blot using the 
indicated antibodies (Xiang et al., 2013). 
 
Immunofluorescence Microscopy 
For fluorescence microscopy, cells were rinsed 3 times in ice cold phosphate buffered saline 
(PBS), fixed with 4% (w/v) paraformaldehyde, quenched with 50 mM NH4Cl in PBS, 
permeabilized in 0.2% (v/v) Triton X-100 in PBS, and blocked for 1 h with PBSB - PBS 
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supplemented with 1% (w/v) bovine serum albumin (BSA) Fraction V (ThermoFisher, Waltham, 
MA) (Tang et al., 2016). Cells were incubated with a primary antibody diluted in PBSB at 
overnight gently rocking at 4°C, thoroughly washed with PBS, and incubated with an FITC-, 
TRITC- or CY5-labeled secondary antibody (1:200 dilution in PBSB) at room temperature for 
30 min. Cells were then washed 3 times with PBS and stained with 1:10,000 Hoechst dye for 3 
min, and then mounted on glass slides with Moviol plus fluorescence brightener (DABCO; 
Acros Organics). Images were captured with a Zeiss Observer fluorescent microscope with a 63x 
oil objective lens and Axiocam Mrm camera. TIF files were exported with AxioVision software 
(Zeiss). For the data in Fig. 3.7B and C, images were collected at random locations on the 
coverslip with the autofocus function of ZEN software at 20x magnification. 
 
Electron Microscopy 
All EM related reagents were from Electron Microscopy Sciences (EMS; Hatfield, PA). Cells 
were fixed in pre-warmed serum-free DMEM, 20 mM HEPES, pH 7.4, 2% glutaraldehyde at 
room temperature for 30 min or 4°C overnight as previously described (Tang et al., 2010a; Wang 
et al., 2005). Cells were washed 2 times with 0.1 M Sodium cacodylate, and post-fixed on ice in 
1% (v/v) reduced Osmium tetroxide, 0.1 M Sodium cacodylate (w/v) and 1.5% cyanoferrate 
(w/v) in water. Cells were rinsed 3 times with 50 mM maleate buffer, pH 5.2, 3 times with water, 
scraped, and pelleted in microcentrifuge tubes for embedding. The EMBED 812 protocol was 
used to embed cells and resin blocks were sectioned to 60 nm with a diamond knife and mounted 
on Formvar-coated copper grids (Tang et al., 2010a). Samples were double contrasted with 2% 
uranyl acetate then with lead citrate and rinsed with copious amounts of water. Grids were 
imaged using a Philips (Amsterdam, Netherlands) transmission electron microscope. Golgi 
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images were captured at 11,000x magnification. Golgi stacks were identified using 
morphological criteria and quantified using standard stereological techniques. A Golgi cisterna 
was identified as a perinuclear membrane within a Golgi stack ≥4 times longer than its width. 
Stack length was measured for the longest cisterna within a Golgi stack using the ruler tool in 
Photoshop Elements 13. For the number of cisternae per stack, the number of cisternae was 
counted. For the number of vesicles per stack, round objects no greater than 80 microns in 
diameter within 0.5 micron distance to a Golgi stack were counted. Golgi morphology was 
quantified from at least 20 cells in each experiment. 
 
Shiga toxin 1B subunit (StxB) transport assay 
Shiga toxin assay was performed as previously described (Selyunin and Mukhopadhyay, 2015b). 
In short, cells were plated onto poly-lysine coated coverslips and cultured overnight, incubated 
with 4 µg/mL purified Shiga toxin 1B subunit (StxB) DMEM at 4°C for 30 min, and then 
washed thoroughly with cold PBS. Cells were then incubated with H2O2 in growth medium for 
10 minutes at 37ºC, washed with growth medium, and further incubated in growth medium 
without H2O2 for an additional 50 min at 37ºC. After treatment, cells were fixed and 
permeabilized as described above, stained with indicated primary and secondary antibodies for 
1.5 h each at room temperature, and analyzed by fluorescence microscopy. 
 
VSV-G protein trafficking and exofacial labelling 
For EndoH treatment and Western blotting, cells in a dish were transfected with the Str-li_VSVG 
wt-SBP-EGFP plasmid for 16 h followed by a 10 min treatment with 1 mM H2O2. Cells were 
then incubated with fresh growth medium containing 40 µM biotin (chase) for the indicated 
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times. Cells were lysed with denaturing buffer (0.5% SDS, 40 mM DTT), boiled at 90°C for 10 
minutes, and treated with (+) or without (-) EndoH in G5 buffer (50 mM Sodium Citrate, pH 5.5) 
at 37°C for 1 h. Reaction was mixed with SDS buffer and analyzed by Western blot for GFP. 
Bands on Western blots were quantified using densitometry analysis. The intensity of the upper 
EndoH resistant band was divided by that of the total of the upper and lower bands to calculate 
the mature/total ratio. 
 
For immunofluorescence analysis of cell surface VSV-G, HeLa cells grown on poly-lysine 
coated coverslips were transfected with the Str-li_VSVG wt-SBP-EGFP plasmid for 16 h. Cells 
were then fixed in 4% paraformaldehyde without permeabilization, blocked with 1% BSA in 
PBS, and incubated with an anti-VSV-G antibody overnight at 4°C. After washing 3 times with 
PBS, the cells were briefly permeabilized with 0.3% Triton X-100 and processed for 
immunofluorescence. 
 
Quantitation and Statistics 
All data represent the mean ± SEM (standard error of the mean) of at least three independent 
experiments unless noted. A statistical analysis was conducted with two-tailed Student’s t-test in 
the Excel program (Microsoft, Redmond, WA). Differences in means were considered 
statistically significant if p ≤ 0.05. Significance levels are: *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 
0.001. Figures were assembled with Photoshop (Adobe, San Jose, CA). For Fig. 3.7C, automatic 
thresholding was performed in ImageJ, and the Golgi-localized M6PR signal was plotted. Over 







Fig. 3.1 H2O2 treatment causes specific degradation of Arl1 and its binding partners 
(A) Effect of H2O2 treatment on indicated proteins. HeLa cells were treated with the indicated 
concentrations of H2O2 for 10 min, collected, and blotted for the indicated proteins. (B) 
Distribution of indicated proteins in membrane and cytosolic fractionations. Control (Ctrl) cells 
and cells treated with 1 mM H2O2 for 10 min were homogenized with a ball-bearing 
homogenizer followed by a low speed centrifugation to prepare post nuclear supernatant (PNS). 
The PNS was then subjected to ultracentrifugation to separate membranes (Mem) from the 





Fig. 3.2 H2O2 treatment causes specific degradation of Arl1 and Golgin-97 by IF 
(A) H2O2 treatment reduces the Golgi localization of Arl1. HeLa cells were treated with the 
indicated concentrations of H2O2 for 10 min, fixed, and stained for Arl1 (red), GM130 (green) 
and DNA (blue). (B) H2O2 treatment reduces the Golgi localization of Golgin-97. HeLa cells 





Fig. 3.3 H2O2 treatment reduces membrane association of golgins in the trans-Golgi 
(A) HeLa cells treated with 1 mM H2O2 for 10 min were stained for GCC88 (left panels), EGFP-
GCC185 expressing HeLa cells with the same treatment were analyzed for GCC185 (right 
panels). Note that GCC88 and GCC185 have reduced signals in the Golgi but diffused signals in 





Fig. 3.4 H2O2 treatment does not cause Golgi fragmentation 
(A) H2O2 treatment does not induce significant Golgi fragmentation. HeLa cells were treated 
with indicated concentrations of H2O2 for 10 min and stained for GM130 and TGN46. Scale bar, 
20 µm. (B) Quantitation of Golgi fragmentation in H2O2-treated cells in A. Results are shown as 
Mean ± SEM from three independent experiments. No significant changes were detected by two-





Fig. 3.5 Short term H2O2 treatment reduces the number of cisternae per Golgi stack 
(A-B) Representative electron micrographs of Golgi profiles in HeLa cells either untreated (Ctrl; 
A) or treated with 1 mM H2O2 for 10 min (H2O2; B). Note that the Golgi stacks contain fewer 
cisternae in the H2O2-treatment compared to Ctrl cells. Scale bar, 0.5 µm. (C-D) Quantitation of 
Golgi stack morphological features of cells in A and B. (E) Summary of quantitation of the 
morphological features of Golgi stacks on the EM images represented in A and B. Results are 
shown as Mean ± SEM; statistical analyses were performed using two-tailed Student's t-tests (*, 





Fig. 3.6 H2O2 treatment alters the Golgi structure. 
HeLa cells were incubated in growth medium without (A) or with 1 mM H2O2 (B) for 10 min 
were analyzed by EM. Shown are a collection of electron micrographs representing the two 
treatments. Consistent aberrations in the Golgi stacks were seen in H2O2-treated cells, in 
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particular a reduction of the cisterna number per Golgi stack, while the cisternal length and the 





Fig. 3.7 H2O2 treatment reduces anterograde and retrograde trafficking  
(A) HeLa cells treated with 1 mM H2O2 for indicated times were analyzed by Western blotting. 
(B) HeLa cells treated as in A were stained for CI-M6PR (red) and GM130 (green). Scale bar, 50 
µm. (C) Quantitation of the Golgi-localized CI-M6PR intensity in B. Statistical analyses were 
performed using two-tailed Student's t-tests in comparison with the control (***, p ≤ 0.001). 
Note the decrease in Golgi-localized CI-M6PR along with the unchanging total protein amount 
in A. (D) Live cells were incubated with Shiga toxin (StxB) on ice followed by a 60 min 
incubation at 37ºC to allow StxB trafficking to the Golgi. Cells were fixed and stained for StxB 
(green) and TGN46 (red). Scale bar, 20 µm. Note the dispersed StxB signals in H2O2 treated 
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cells, which is more concentrated in the Golgi region in control cells. (E) VSV-G trafficking 
assay using the RUSH system. Cells transfected with the Str-li_VSVG wt-SBP-EGFP plasmid 
were treated with or without 1 mM H2O2 for 10 minutes followed by VSV-G release from the 
ER for indicated times. Cell lysate was treated with or without EndoH and blotted for GFP. (F) 
Bands in E were quantified using densitometry analysis. The intensity of the upper EndoH 
resistant band was divided by that of the total of the upper and lower bands to calculate the 
mature/total ratio. Results are shown as Mean ± SEM from three independent experiments. 
Statistical analyses were performed using two-tailed Student's t-tests in comparison with the 
control (*, p ≤ 0.05; **, p ≤ 0.01). (G) Cells were treated as in E, fixed with PFA without 
permeabilization, and stained with an anti-VSVG antibody that recognizes its luminal domain. 





Fig. 3.8 H2O2 treatment causes golgin-97 degradation by cytoplasmic proteases. 
(A) HeLa cells were treated with 400 nM BafA1 for 2 hours, followed by the addition of 1 mM 
H2O2 in the last 10 min and analyzed by Western blots for the indicated proteins. (B) 
Densitometric analysis of Golgin-97 blots in A from three independent experiments. (C) HeLa 
cells were treated as in A and stained for GM130 (green), Golgin-97 (red), and DNA (blue). 
Scale bar, 20 µm. (D) Cells were treated with 20 µM MG132 for 4 hours, followed by the 
addition of 1 mM H2O2 in the last 10 min and analyzed by Western blots for indicated proteins. 
(E) Densitometric analysis of the Golgin-97 protein level on Western blot in D from three 
independent experiments. Results are shown as Mean ± SEM. Statistical analyses were 
performed using two-tailed Student's t-tests (**, p ≤ 0.01, ***, p ≤ 0.001). (F) HeLa cells were 
co-treated with MG132 as in D and stained for GM130, Golgin-97 and DNA. Scale bar, 20 µm. 
(G) HeLa cells co-treated with or without a protease inhibitor cocktail and 1 mM H2O2 for 10 
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min were analyzed by Western blotting. (H) Quantitation of Golgin-97 Western blot in G with 
densitometric analysis. (I) Cells treated as in G were stained for Golgin-97 (red), GM130 
(green), and DNA (blue). Scale bar, 20 µm.Results are shown as Mean ± SEM from three 
independent experiments. Statistical analyses were performed using two-tailed Student's t-tests 














Conclusions and Future Directions 
 
4.1 Concluding remarks 
The conclusion of this research is that the Golgi possesses its own mechanisms to sense and 
respond to various stresses. It has been commonly thought in the past that Golgi stress is a mere 
consequence of the expanding capacity of the ER during cellular stress. This, so the theory goes, 
leads to a failure of the Golgi as it is over-burdened with misfolded or improperly folded 
proteins, which in turn affect Golgi functions (Oku et al., 2011). However, results do not support 
this hypothesis for two reasons: First, although three ER stress inducers, TG, Tm and DTT, all 
induced ER stress, only TG treatment caused Golgi fragmentation. Second, TG induced Golgi 
fragmentation at a lower dose within a time window when UPR was undetectable. Therefore, 
Golgi fragmentation occurs independently of ER stress. Furthermore, this study revealed a novel 
mechanism that coordinates Golgi structure and perhaps function: TG treatment increases 
cytoplasmic Ca2+, which activates PKCα, that subsequently phosphorylates GRASP55, impairing 
its function in Golgi structure formation. GRASP55 therefore provides the conceptual link 





In contrast to some other Golgi stresses such as thapsigargin treatment that triggers Golgi 
fragmentation (Ireland et al., 2019), H2O2 did not cause obvious Golgi fragmentation, nor 
apoptosis. Here it was revealed that H2O2 treatment induced a rapid degradation of Golgi 
tethering proteins on the trans-Golgi, including Arl1, Golgin-97 and Golgin-245. This loss 
coincided with a stark reduction of the cisternal number per Golgi stack and impaired both 
anterograde and retrograde trafficking functions. Further results indicate that H2O2-stress 
induced ROS activates a cytoplasmic protease to selectively degrade Arl1, Golgin-97 and 
Golgin-245 on the trans-Golgi. This happened independently of apoptosis and necrosis induced 
proteolytic activation. In this study we have identified Golgi proteins and Golgi functions as 
novel targets of ROS-toxicity in cells, in contrast to the fragmentation phenotype seen in 
Chapter II. Furthermore the work has identified specific targets of ROS on the Golgi, Arl1, 
Golgin-97, and Golgin-245.  
 
The experiments in this study were designed to define intrinsic Golgi stress response 
mechanisms. It was found that the Golgi indeed is a target to receive physiological inputs from 
the cell or the environment to increase or decrease functional outputs. Understanding the specific 
regulatory machinery of the Golgi apparatus during stress can aid in the discovery of ways to 
manipulate Golgi health and help support cellular homeostasis and organism health. 
 
4.2 Future directions 
An outstanding question in the Golgi field has been how GRASP65 and GRASP55 remain 
segregated into distinct Golgi compartments. The N-terminal GRASP55 domain is 83% similar 
and 67% identical to that of GRASP65 in human (Fig. 4.1A). This has led to the conclusion that 
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GRASP55 and GRASP65 may stack different regions of the Golgi (Pfeffer, 2001). However, the 
mechanism controlling this biological distinction remains unsolved. 
 
One possible mechanism of segregations could be palmitoylation of GRASPs. Palmitoylated 
proteins tend to be trafficked toward the plasma membrane, whereas de-palmitoylated proteins 
tend to make their way back toward endosomal and Golgi membranes. Palmitoylation is also 
reversible, unlike myristoylation. Palmitoylation occurs at cysteine residues and less frequently 
at serine residues within proteins. Human GRASP55 differ in both cysteine and serine residues 
with its GRASP65 counterpart. It will be interesting to know if one or more of these sites is 
available for palmitoylation. 
 
Scientific inquiry has had several major shifts over the recent centuries and many of these shifts 
have involved dramatic improvements in imaging. What is needed next is spatial separation of 
individual proteins at the ultrastructural level. Super-resolution has brought us closer to 
achieving this, but electron microscopy will be needed to go further. Utilization of Apex2-GBP, 
or a derivative technique, will allow cell biologists to label proteins using EM. To that end, a 
technique was developed for the lab employing apex enzyme labelled Golgi proteins. Some of 
the progress is shown in Fig. 4.1B-E.  
 
The apex tool has the power to directly test the hypothesis that palmitoylation of GRASP 
homologues controls their segregation within the Golgi. By creating alanine point mutations in 
the cysteine residues of GRASP proteins and comparing the localization patterns between mutant 
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and wild type proteins using apex, one could ask if mutants would appear more on the cis-Golgi 
than they normally do. 
 
To continue the work, a researcher in the Wang lab could 1) improve and clarify previous 
findings that GRASP55 and GRASP65 localize to inter-cisternal spaces of the Golgi stack as 
previously shown, and 2) identify the mechanism of how GRASP homologues, GRASP55 and 







Fig 4.1 GRASP55 localizes to the inter-cisternal spaces of the Golgi stack 
(A) BLAST sequence alignment of human GRASP55 and human GRASP65 N-terminus 
showing the number of identities, mismatches (gaps), and conservative substitutions (+). (B) 
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HeLa cells co-expressing Apex-GBP (Apex) and Histone 2B-GFP (H2B-GFP) after undergoing 
a DAB reaction. The nucleus exhibits with a high degree of opaque reaction product compared to 
untransfected cells indicated by the asterisk (*) (please see section 4.4 for Materials and 
Methods). (C) Co-expression of Apex-GBP and the Golgi structural protein GRASP55-GFP 
(GRASP55). The Golgi is shown occupying a central position in the cell compared to the H2B 
control cells in B. Scale bar, 20 microns. (D) EM visualization of untransfected HeLa cell 
showing normal Golgi stacks, G. Also visible is the nucleus N. (E) EM visualization of HeLa 
cell co-transfected with Apex2-GBP and GRASP55-GFP plasmids. The dark, electron dense 
region within the Golgi, G, stacks suggests an inter-cisternal enrichment of GRASP55, whereas 
light microcopy can never establish this level of detail. Also visible is the nucleus, N. Scale bar, 




4.4 Materials and Methods 
Basic Local Alignment Search Tool (BLAST) 
Protein BLAST was performed using National Center for Biotechnology Information's (NCBI) 
online alignment software. Amino acid sequences were obtained by aligning two or more 
sequences. The first subject sequence was the first 212 positions of human GRASP55 
(GORASP2; NCBI Reference Sequence: NP_001188357.1), and the query sequence was the first 
212 positions of human GRASP65 (GORASP1; NCBI Reference Sequence: XP_006713364.1).  
 
Reagents and Plasmids  
All EM related reagents were from Electron Microscopy Sciences (EMS; Hatfield, PA). The 
Apex2-GBP plasmid was purchased from Addgene (#67651). The H2B-GFP plasmid was 
purchased from Addgene (#11680). GRASP55-GFP was made in house using the pEGFP-N1 
vector (Zhang et al., 2018) 
 
Cell Culture and Drug Treatments  
HeLa were obtained from ATCC (Manassas, VA), cultured in Dulbecco's modified Eagle’s 
medium (DMEM; ThermoFisher) supplemented with 10% fetal bovine serum (FBS; Gemini 
Bio-Products, Sacramento, CA) and 100 units/ml penicillin-streptomycin at 37°C with 5% CO2, 
and routinely screened for mycoplasma contamination. Cells were grown on glass coverslips 
according to standard tissue culture methods (Tang et al., 2011). Coverslips were pre-coated with 
poly-lysine (Gibco) to aid in cell attachment. 
 
Apex Electron Microscopy 
115 
 
Hela cells were plated onto 6 cm tissue culture dishes with a coverslip 24 h prior to transfection. 
Cells were transfected with Apex2-GBP with either mock, H2B-GFP or GRASP55-GFP 
plasmids for 16 h. Cells were fixed in pre-warmed serum-free DMEM, 20 mM HEPES, pH 7.4, 
2% glutaraldehyde at room temperature for 1 h or 4°C overnight as previously described (Tang 
et al., 2010a; Wang et al., 2005). The DAB reaction buffer was prepared fresh and used 
immediately (1 mg/mL solution of 3’3-diaminobenzidine tetrahydrochloride (Sigma-Aldrich) in 
0.1 M sodium cacodylate). Undissolved precipitate was removed with syringe filtration using a 
0.2 µm filter. Cells were washed 2 times with DAB buffer. This initial wash was then replaced 
with DAB reaction mixture after adding H2O2 (5.88 mM), and cells were allowed to incubate for 
60 minutes. The cells were next washed 3x with pure 0.1 M cacodylate buffer followed by 10x 
with ddH2O. Coverslips were collected and imaged using brightfield (Fig. 4.1B-C). Remaining 
cells were then incubated in 2% filtered uranyl acetate solution at 4°C, and rinsed with water 
until no traces of yellow remained (about 3 times). The EMBED 812 protocol was used to embed 
cells and resin blocks were sectioned to 60 nm with a diamond knife and mounted on Formvar-
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